Abstract is: Pneumocystis jirovecii (previously P. carinii) is a yeast-like fungus of the genus Pneumocystis. The causative organism of Pneumocystis pneumonia, it is an important human pathogen, particularly among immunocompromised hosts. Prior to its discovery as a human-specific pathogen, P. jirovecii was known as P. carinii.
| taxon | Q16521 |
| P9076 | Australian Fungi ID | 60022107 |
| P12292 | Biota of New Zealand ID | b1333e74-aae3-4064-ac3d-fab6a48de5cc |
| P1939 | Dyntaxa ID | 260000 |
| P830 | Encyclopedia of Life ID | 200101 |
| P646 | Freebase ID | /m/0b73rx7 |
| P846 | GBIF taxon ID | 2610978 |
| P6433 | Global Species ID | 1875137 |
| P1391 | Index Fungorum taxon ID | 450385 |
| P3827 | JSTOR topic ID (archived) | pneumocystis-jiroveci |
| P6366 | Microsoft Academic ID | 2777559004 |
| P962 | MycoBank taxon name ID | 450384 |
| P3240 | NBN System Key | NHMSYS0020535956 |
| P685 | NCBI taxonomy ID | 42068 |
| P2752 | New Zealand Organisms Register ID | 75b8c351-efd0-4789-b7f2-68568114deba |
| P9157 | Open Tree of Life ID | 405725 |
| P10283 | OpenAlex ID | C2777559004 |
| C2993443204 | ||
| P11143 | WikiProjectMed ID | Pneumocystis jirovecii |
| P3471 | WikiSkripta article ID | 70201 |
| P138 | named after | Otto Jírovec | Q327282 |
| P171 | parent taxon | Pneumocystis | Q133125 |
| P1813 | short name | P. jirovecii | |
| P6507 | taxon author citation | Frenkel | |
| P225 | taxon name | Pneumocystis jirovecii | |
| Pneumocystis jiroveci | |||
| P105 | taxon rank | species | Q7432 |
| Q51810002 | 'Septrin psychosis' among renal transplant patients with Pneumocystis jirovecii pneumonia. |
| Q94144419 | 1024. Evaluation of Atovaquone Prescribing for Pneumocystis jiroveci Pneumonia (PJP) Prophylaxis |
| Q59327447 | 1130. Low Risk of Pneumocystis jiroveci Pneumonia in Patients With Waldenstrom’s Macroglobulinemia on Ibrutinib |
| Q59328757 | 1487. Variability of Pneumocystis jirovecii Prophylaxis Use Among Pediatric Solid Organ Transplant Providers |
| Q59328112 | 1908. Development of an Electronic Health Record Generated Alert for Prophylaxis Against Pneumocystis Jirovecii Pneumonia in the Setting of High-Dose Steroids |
| Q128966534 | 2 cases of Pneumocystis Jirovecii Pneumonia occurring during treatment of Cushing's Syndrome. Is there a case for prophylaxis of PJP in the treatment of severe hypercortisolism? |
| Q59328660 | 2049. Pneumocystis jiroveci Detection by Nested PCR in HIV-Infected Peruvian Patients |
| Q94141367 | 252. Development and Evaluation of a Novel MultiCode Real-Time PCR Assay for the Detection of Pneumocystis jirovecii in Bronchoalveolar Lavage Fluid and Induced Sputum |
| Q59334656 | 2566. Diagnosis of Pneumocystis jiroveci Pneumonia in HIV-Negative Immunocompromised Patients: Is the Gomori-Methenamine Silver Stain of Bronchoalveolar Lavage Fluid the Gold Standard or Sub-Standard? |
| Q94136879 | 2621. Influence of HIV Exposure Status on Carriage Rates and Density of Streptococcus Pneumoniae and Pneumocystis Jirovecii in Zambian Children |
| Q94133803 | 2695. Pneumocystis jirovecii Pneumonia in the Era of Effective Prophylaxis Following Hematopoietic Stem Cell Transplant |
| Q121223757 | 352. Evaluation of Serial Serum (1-- >3)-b-D-glucan Assay in Patients with Invasive candidiasis, Pneumocystis Jiroveci Pneumonia and Aspergillosis |
| Q94122703 | 379. Clinical Management of HIV-associated Pneumocystis jirovecii Pneumonia in Rural Nigerian Communities: Public Health Interventions and Impact |
| Q59334169 | 401. Pneumocystis jirovecii Pneumonia in Renal Transplant Recipients After a 6-Month Trimethoprim–Sulfamethoxazole Prophylaxis: A Case–Control Study |
| Q59328044 | 402. Breakthrough Pneumocystis jirovecii Pneumonia Among Cancer Patients: Opportunity for Antimicrobial Stewardship? |
| Q126552257 | 614: PNEUMOCYSTIS JIROVECII PNEUMONIA IN AN IMMUNOCOMPETENT PATIENT ON VV ECMO |
| Q127130350 | 679 Epidemiology and Impact of Pneumocystis jirovecii Pneumonia in Hospitalized Patients With Inflammatory Bowel Disease |
| Q125631812 | Pneumocystis jirovecii pneumonia after |
| Q33565975 | A 32-Year-Old Female with AIDS, Pneumocystis jiroveci Pneumonia, and Methemoglobinemia |
| Q40077720 | A Case Report of Pneumocystis Jiroveci Pneumonia in a Patient with Metastatic Breast Cancer |
| Q128154420 | A Case Report of Primaquine Associated Methemoglobinemia in a Man With Pneumocystis Jirovecii Pneumonia Following Cardiac and Renal Transplantation |
| Q42196009 | A Case of Pneumocystis jirovecii Pneumonia in a Severely Malnourished, HIV-Negative Patient: A Role for Malnutrition in Opportunistic Infections? |
| Q40737087 | A Case of Pneumonia Caused by Pneumocystis Jirovecii and Cryptococcus Neoformans in a Patient with HTLV-1 Associated Adult T- Cell Leukemia/Lymphoma: Occam's Razor Blunted |
| Q35877664 | A Case of Pneumonia Caused by Pneumocystis jirovecii Resistant to Trimethoprim-Sulfamethoxazole |
| Q112279703 | A Clinically Applicable Nomogram for Predicting the Risk of Invasive Mechanical Ventilation in Pneumocystis jirovecii Pneumonia |
| Q104479584 | A Comprehensive Evaluation of Risk Factors for Pneumocystis Jirovecii Pneumonia in Adult Solid Organ Transplant Recipients: a Systematic Review and Meta-Analysis |
| Q114198037 | A DRY COUGH CONUNDRUM: A RARE CASE OF PNEUMOCYSTIS JIROVECII PNEUMONIA IN SYSTEMIC LUPUS ERYTHEMATOUS PATIENT ON HYDROXYCHLOROQUINE |
| Q90627112 | A MULTIVARIATE PROGNOSTIC SCORE FOR PREDICTING MORTALITY OF ACQUIRED IMMUNODEFICIENCY SYNDROME PATIENTS WITH HYPOXEMIC RESPIRATORY FAILURE AND PNEUMOCYSTIS JIROVECI PNEUMONIA |
| Q89564980 | A Multivariable Prediction Model for Pneumocystis jirovecii Pneumonia in Hematology Patients with Acute Respiratory Failure |
| Q46479577 | A Pneumocystis jirovecii pneumonia outbreak in a single kidney-transplant center: role of cytomegalovirus co-infection |
| Q127151254 | A Prospective Study of IV Pentamidine for Pneumocystis Jirovecii Pneumonia Prophylaxis in Adult Patients with Hematologic Malignancies Undergoing Hematopoietic Stem Cell Transplant or Chemotherapy |
| Q96607666 | A Rare Case of Splenic Pneumocystis jirovecii in a HIV-Positive Patient |
| Q127111514 | A Retrospective Analysis of Pneumocystis Jirovecii Pneumonia Infection in Patients Receiving Idelalisib in Clinical Trials |
| Q128277137 | A Study on the Incidence of Pneumocystis Jiroveci Pneumoniae in HIV Patients in a Tertiary Care Hospital |
| Q93273783 | A Tale of 2 Pneumos: The Impact of Human Immunodeficiency Virus Exposure or Infection Status on Pediatric Nasopharyngeal Carriage of Streptococcus pneumoniae and Pneumocystis jiroveci: A Nested Case Control Analysis From the Pneumonia Etiology Resea |
| Q40295585 | A case of AIDS with Pneumocystis jirovecii pneumonia which required differentiation from ANCA-related lung disease |
| Q36789445 | A case of Pneumocystis jiroveci pneumonia after bendamustine-based chemotherapy for refractory diffuse large B-cell lymphoma |
| Q51983970 | A case of Pneumocystis jiroveci pneumonia in X-linked agammaglobulinaemia treated with immunosuppressive therapy: a lesson for immunologists. |
| Q40417816 | A case of Pneumocystis jiroveci pneumonia that presented with cavity and cystic changes in a malignant thymoma patient |
| Q40321176 | A case of Pneumocystis jirovecii pneumonia after kidney transplantation with re-exacerbation following therapy |
| Q40200408 | A case of new-onset rheumatoid vasculitis becoming evident in the course of treatment for Pneumocystis jirovecii pneumonia |
| Q39510140 | A case report of pulmonary coinfection of Strongyloides stercoralis and Pneumocystis jiroveci |
| Q43514860 | A cluster of Pneumocystis infections among renal transplant recipients: molecular evidence of colonized patients as potential infectious sources of Pneumocystis jirovecii |
| Q84512442 | A cluster of Pneumocystis jirovecii infection among outpatients with rheumatoid arthritis |
| Q92330617 | A co-infection of varicella-zoster virus and Pneumocystis jirovecii in a non-HIV immunocompromised patient: a case report |
| Q45169752 | A comparison of capillary electrophoresis and direct sequencing in upstream conserved sequence region analysis of Pneumocystis jirovecii strains |
| Q45763211 | A dose-escalation regimen of trimethoprim-sulfamethoxazole is tolerable for prophylaxis against Pneumocystis jiroveci pneumonia in rheumatic diseases |
| Q95380751 | A fatal case of Pneumocystis jirovecii pneumonia in a breast cancer patient receiving weekly paclitaxel and trastuzumab |
| Q39970486 | A followup study of asymptomatic carriers of Pneumocystis jiroveci during immunosuppressive therapy for rheumatoid arthritis |
| Q40341122 | A heart transplant recipient lost due to Pneumocystis jiroveci pneumonia under trimethoprim-sulfamethoxazole prophylaxis: case report. |
| Q40310912 | A highly sensitive novel PCR assay for detection of Pneumocystis jirovecii DNA in bronchoalveloar lavage specimens from immunocompromised patients |
| Q33850595 | A limited number of ITS haplotypes defines the diversity of Pneumocystis jirovecii strains in Sweden |
| Q92075135 | A multi-centered study of Pneumocystis jirovecii colonization in patients with respiratory disorders: Is there a colonization trend in the elderly? |
| Q37713483 | A multiplex real-time PCR assay for identification of Pneumocystis jirovecii, Histoplasma capsulatum, and Cryptococcus neoformans/Cryptococcus gattii in samples from AIDS patients with opportunistic pneumonia |
| Q84417070 | A new method for the detection of Pneumocystis jirovecii using flow cytometry |
| Q24646693 | A new name (Pneumocystis jiroveci) for Pneumocystis from humans |
| Q96024416 | A novel approach to resolve severe mediastinal and subcutaneous emphysema occurring in Pneumocystis jirovecii pneumonia using vacuum-assisted closure therapy |
| Q90757317 | A novel diagnostic approach for Pneumocystis jirovecii pneumonia using fine-needle aspiration, electromagnetic navigational bronchoscopy and rapid on-site evaluation |
| Q57586333 | A prognostic scoring tool for identification of patients at high and low risk of death from HIV-associated Pneumocystis jirovecii pneumonia |
| Q64973945 | A rare case of an HIV-seronegative AIDS patient with Pneumocystis jirovecii pneumonia. |
| Q92559681 | A retrospective study of patients with systemic lupus erythematosus combined with Pneumocystis jiroveci pneumonia treated with caspofungin and trimethoprim/sulfamethoxazole |
| Q129522996 | A simple and efficient DNA extraction from respiratory samples for PCR detection of Pneumocystis jirovecii |
| Q34531814 | A single-copy gene encodes Kex1, a serine endoprotease of Pneumocystis jiroveci |
| Q40078862 | A study on the colonization of Pneumocystis jirovecii among outpatients during cancer chemotherapy and among healthy smokers |
| Q37491569 | A systematic review of two different trimetoprim-sulfamethoxazole regimens used to prevent Pneumocystis jirovecii and no prophylaxis at all in transplant recipients: appraising the evidence. |
| Q46620223 | AB027. Newly diagnosed chronic granulomatous disease in a thirty four year old woman with pneumocystis jiroveci pneumonia. |
| Q38389061 | AIDS-related Pneumocystis jirovecii genotypes in French Guiana. |
| Q43278535 | Ab initio calcineurin inhibitor-based monotherapy immunosuppression after liver transplantation reduces the risk for Pneumocystis jirovecii pneumonia. |
| Q94530056 | Ability of quantitative PCR to discriminate Pneumocystis jirovecii pneumonia from colonization |
| Q37164752 | Absence of Pneumocystis jiroveci pneumonia in liver transplantation recipients receiving short-term (3-month) prophylaxis |
| Q39242862 | Absence of Pneumocystis jirovecii Colonization in Human Immunodeficiency Virus-Infected Individuals With and Without Airway Obstruction and With Undetectable Viral Load |
| Q82979877 | Absence of Pneumocystis jirovecii dihydropteroate synthase gene mutations among samples from a group of AIDS patients in China |
| Q64127828 | Absence of dihydropteroate synthase gene mutations in Pneumocystis jirovecii isolated from Swedish patients |
| Q90356094 | Absence of dihydropteroate synthase gene mutations in Pneumocystis jirovecii strains isolated from Aegean region of Turkey |
| Q54590274 | Absence of dihydropteroate synthase mutations in Pneumocystis jirovecii from Brazilian AIDS patients. |
| Q43761014 | Accuracy of a routine real-time PCR assay for the diagnosis of Pneumocystis jirovecii pneumonia. |
| Q83995286 | Accuracy of serum LDH elevation for the diagnosis of Pneumocystis jiroveci pneumonia |
| Q44088311 | Accuracy of β-D-glucan for the diagnosis of Pneumocystis jirovecii pneumonia: a meta-analysis. |
| Q91427643 | Acute Kidney Injury Secondary to Hypercalcemia in a Kidney Transplant Patient With Pneumocystis jirovecii Pneumonia: A Case Report |
| Q35998811 | Acute exacerbation of interstitial pneumonia associated with rheumatoid arthritis during the course of treatment for Pneumocystis jirovecii pneumonia: a case report |
| Q42870586 | Acute fibrinous and organizing pneumonia in a patient with HIV infection and Pneumocystis jiroveci pneumonia |
| Q44455171 | Acute generalised exanthematous pustulosis induced by Pneumocystis jirovecii pneumonia prophylaxis with dapsone. |
| Q36082455 | Acute microbiologically negative hypoxic interstitial pneumonia on HAART: Immune Reconstitution Inflammatory Syndrome unmasking Pneumocystis jiroveci infection with an atypical presentation |
| Q57610456 | Acute psychosis related to use of trimethoprim/sulfamethoxazole in the treatment of HIV-infected patients with Pneumocystis jirovecii pneumonia: a multicentre, retrospective study |
| Q38654568 | Added Value of Next-Generation Sequencing for Multilocus Sequence Typing Analysis of a Pneumocystis jirovecii Pneumonia Outbreak1. |
| Q38951524 | Adjunctive Corticosteroids for Pneumocystis jirovecii Pneumonia in Non-HIV-infected Patients: A Systematic Review and Meta-analysis of Observational Studies |
| Q46475893 | Adjunctive corticosteroid treatment of clinical Pneumocystis jiroveci pneumonia in infants less than 18 months of age--a randomised controlled trial |
| Q24186646 | Adjunctive corticosteroids for Pneumocystis jiroveci pneumonia in patients with HIV infection |
| Q24815855 | Adjunctive corticosteroids for Pneumocystis jiroveci pneumonia in patients with HIV infection: a meta-analysis of randomised controlled trials |
| Q24245547 | Adjunctive corticosteroids for Pneumocystis jiroveci pneumonia in patients with HIV-infection |
| Q36524565 | Adjunctive corticosteroids for the treatment of Pneumocystis jiroveci pneumonia in patients with HIV: A meta-analysis |
| Q99730707 | Aerodigestive adverse effects during intravenous pentamidine infusion for Pneumocystis jirovecii pneumonia prophylaxis |
| Q48650073 | Aggressive immunosuppressant reduction and long-term rejection risk in renal transplant recipients with Pneumocystis jiroveci pneumonia |
| Q127821476 | Airborne Interindividual Transmission of Pneumocystis jirovecii |
| Q42702120 | Airborne spread of Pneumocystis jirovecii |
| Q86440154 | All patients with leukemia are not equally at risk of contracting Pneumocystis jirovecii pneumonia |
| Q84596488 | Alveolar and blood T lymphocyte profiles in Pneumocystis jirovecii-positive patients: effects of HIV status |
| Q28391022 | Ambient air pollution associated with suppressed serologic responses to Pneumocystis jirovecii in a prospective cohort of HIV-infected patients with Pneumocystis pneumonia |
| Q37533401 | An Unusual Case of Cystic Fibrosis Associated Pneumocystis jiroveci Pneumonia in an Infant |
| Q89875754 | An Usual Presentation of Pneumocystis jirovecii Pneumonia in a Woman Treated With Immune Checkpoint Inhibitor |
| Q36616349 | An analysis of the utilisation of chemoprophylaxis against Pneumocystis jirovecii pneumonia in patients with malignancy receiving corticosteroid therapy at a cancer hospital |
| Q42286792 | An epidemic of Pneumocystis jiroveci pneumonia in a renal transplantation center: role of T-cell lymphopenia. |
| Q28296417 | An outbreak of Pneumocystis jiroveci pneumonia with 1 predominant genotype among renal transplant recipients: interhuman transmission or a common environmental source? |
| Q90012289 | An overview of Pneumocystis jirovecii pneumonia for the African generalist practitioner |
| Q46381450 | Analysis of Pneumocystis jirovecii DHPS alleles implicated in sulfamethoxazole resistance using an Escherichia coli model system |
| Q44773073 | Analysis of USRDS: incidence and risk factors for Pneumocystis jiroveci pneumonia |
| Q43449698 | Analysis of clinical features of non-HIV Pneumocystis jirovecii pneumonia |
| Q90771900 | Anidulafungin as an alternative treatment for Pneumocystis jirovecii pneumonia in patients who cannot tolerate trimethoprim/sulfamethoxazole |
| Q35793264 | Antibody response to Pneumocystis jirovecii major surface glycoprotein |
| Q37261922 | Antibody responses against Pneumocystis jirovecii in health care workers over time |
| Q54525557 | Antiphospholipid antibodies investigation in Pneumocystis jirovecii carriers. |
| Q39571954 | Apical Pneumocystis jiroveci as an AIDS defining illness: A case report illustrating a change in the paradigm |
| Q43695470 | Apparent Absence of Pneumocystis Jirovecii Colonization in Cuban HIV-infected Children and Adolescents |
| Q54604165 | Apparent absence of Pneumocystis jirovecii in healthy subjects. |
| Q34590866 | Application of real time polymerase chain reaction targeting kex 1 gene & its comparison with the conventional methods for rapid detection of Pneumocystis jirovecii in clinical specimens |
| Q83019830 | Aspergillus fumigatus, Pneumocystis jiroveci, Klebsiella pneumoniae & Mycoplasma fermentans co-infection in a HIV infected patient with respiratory conditions from Southern India |
| Q36790813 | Assembly and annotation of Pneumocystis jirovecii from the human lung microbiome |
| Q38660319 | Assessment of cytomegalovirus and cell-mediated immunity for predicting outcomes in non-HIV-infected patients with Pneumocystis jirovecii pneumonia |
| Q44598922 | Association between a specific Pneumocystis jiroveci dihydropteroate synthase mutation and failure of pyrimethamine/sulfadoxine prophylaxis in human immunodeficiency virus-positive and -negative patients |
| Q37096855 | Asymptomatic carriage of Pneumocystis jiroveci in elderly patients with rheumatoid arthritis in Japan: a possible association between colonization and development of Pneumocystis jiroveci pneumonia during low-dose MTX therapy |
| Q35536039 | Asymptomatic carriage of Pneumocystis jiroveci in subjects undergoing bronchoscopy: a prospective study |
| Q41747945 | Asymptomatic carriage of Pneumocystis jirovecii and cytomegalovirus in lungs of immunocompetent patients |
| Q83839545 | Atovaquone versus trimethoprim-sulfamethoxazole as Pneumocystis jirovecii pneumonia prophylaxis following renal transplantation |
| Q84935707 | Atypical Pneumocystis jiroveci pneumonia with multiple nodular granulomas after rituximab for refractory nephrotic syndrome |
| Q42383009 | Atypical Pneumocystis jirovecii pneumonia in previously untreated patients with CLL on single-agent ibrutinib |
| Q54239674 | Atypical Presentation of Pneumocystis jirovecii Infection in HIV Infected Patients: Three Different Manifestations. |
| Q92464818 | Atypical presentation of Pneumocystis jirovecii pneumonia in a patient with rheumatoid arthritis treated with tofacitinib: a case presentation |
| Q55265868 | Atypical radiographic manifestation in Pneumocystis jirovecii pneumonia. |
| Q49916269 | Atypical radiological presentation of pulmonary invasion of diffuse large B-cell lymphoma mimicking Pneumocystis jiroveci pneumonia |
| Q46391595 | Balancing the risks and benefits of prophylaxis: a reply to "Pneumocystis jiroveci pneumonia in patients treated with systemic immunosuppressive agents for dermatologic conditions". |
| Q35193330 | Blood (1->3)-beta-D-glucan as a diagnostic test for HIV-related Pneumocystis jirovecii pneumonia. |
| Q39171774 | Bone marrow infection by Pneumocystis jirovecii |
| Q84077799 | Bone marrow involvement by Pneumocystis jiroveci |
| Q48594929 | Brain abscesses in HIV-positive patients due to Pneumocystis jiroveci |
| Q84992005 | Breakthrough Pneumocystis jiroveci pneumonia under pentamidine prophylaxis: imaging findings revisited |
| Q40427981 | Bronchiolitis obliterans organizing pneumonia associated with Pneumocystis jiroveci infection in orthotopic liver transplantation |
| Q56964964 | C-reactive protein and procalcitonin to discriminate between tuberculosis, Pneumocystis jirovecii pneumonia, and bacterial pneumonia in HIV-infected inpatients meeting WHO criteria for seriously ill: a prospective cohort study |
| Q127096758 | CONCURRENT DISSEMINATED MYCOBACTERIUM AVIUM COMPLEX AND PNEUMOCYSTIS JIROVECI PNEUMONIA INFECTION PRESENTING AS LUNG ABSCESS |
| Q44593136 | Cardiac arrest during serve Pneumocystis jiroveci infection in an immune-compromised patient after splenectomy |
| Q43595290 | Case report: An AIDS patient with adrenal crisis after immune reconstitution inflammatory syndrome due to Pneumocystis jiroveci pneumonia |
| Q30429444 | Case report: oseltamivir-induced resistant pandemic influenza A (H1N1) virus infection in a patient with AIDS and Pneumocystis jirovecii pneumonia |
| Q89256834 | Caspofungin salvage therapy in Pneumocystis jirovecii pneumonia |
| Q44985971 | Causes of first hospitalization among 1121 HIV-infected children: comparison of the pre-Pneumocystis jiroveci pneumonia prophylaxis, pre-antiretroviral therapy and antiretroviral therapy periods |
| Q102155390 | Cavitary lung lesions caused by Pneumocystis jirovecii in setting of common variable immune deficiency |
| Q43063259 | Cellular and cytokine changes in the alveolar environment among immunocompromised patients during Pneumocystis jirovecii infection. |
| Q35193298 | Cellular profiles of bronchoalveolar lavage fluid and their prognostic significance for non-HIV-infected patients with Pneumocystis jirovecii pneumonia |
| Q130154643 | Characteristics and Prognosis Factors of Pneumocystis jirovecii Pneumonia According to Underlying Disease |
| Q94504326 | Characterization of Pneumocystis jirovecii pneumonia at three tertiary comprehensive hospitals in southern China |
| Q48241819 | Characterization of thioredoxin reductase genes (trr1) from Pneumocystis carinii and Pneumocystis jiroveci |
| Q46217076 | Children with Pneumocystis jiroveci pneumonia and acute hypoxaemic respiratory failure admitted to a PICU, Durban, South Africa |
| Q42842977 | Choroiditis and exudative macular detachments in a post transplant leukaemic patient: an unusual presentation of Pneumocystis jiroveci infection |
| Q84141131 | Chronic Pneumocystis jiroveci presenting as asymptomatic granulomatous pulmonary nodules in lymphoma |
| Q90532554 | Circulating and Pulmonary T-cell Populations Driving the Immune Response in Non-HIV Immunocompromised Patients with Pneumocystis jirovecii Pneumonia |
| Q47742779 | Circulating genotypes of Pneumocystis jirovecii and its clinical correlation in patients from a single tertiary center in India |
| Q57586469 | Climate and genotypes of Pneumocystis jirovecii |
| Q80430694 | Climatic factors and Pneumocystis jiroveci infection in southern Spain |
| Q45070975 | Clindamycin-primaquine for pneumocystis jiroveci pneumonia in renal transplant patients. |
| Q96342156 | Clinical Characteristics and Risk Factors for Pneumocystis Jirovecii Pneumonia during Immunosuppressive Treatment in Patients with Ulcerative Colitis: A Retrospective Study |
| Q36185559 | Clinical Course, Radiological Manifestations, and Outcome of Pneumocystis jirovecii Pneumonia in HIV Patients and Renal Transplant Recipients |
| Q40118082 | Clinical Manifestations and Prognostic Factors of Pneumocystis jirovecii Pneumonia without HIV. |
| Q57826475 | Clinical Profile of Pneumocystis jirovecii Infection - A Comparative Study |
| Q36152034 | Clinical Usefulness of HRCT in Assessing the Severity of Pneumocystis jirovecii Pneumonia: A Cross-sectional Study |
| Q99347558 | Clinical characteristics and prevalence of dihydropteroate synthase gene mutations in Pneumocystis jirovecii-infected AIDS patients from low endemic areas of China |
| Q38065099 | Clinical characteristics and risk factors for Pneumocystis jirovecii pneumonia in patients with rheumatoid arthritis receiving adalimumab: a retrospective review and case-control study of 17 patients. |
| Q61649388 | Clinical characteristics and risk factors for Pneumocystis jirovecii pneumonia in patients with rheumatoid arthritis receiving adalimumab: a retrospective review and case–control study of 17 patients |
| Q35177009 | Clinical characteristics of hospital-onset Pneumocystis pneumonia and genotypes of Pneumocystis jirovecii in a single tertiary centre in Korea. |
| Q37417520 | Clinical efficacy of first- and second-line treatments for HIV-associated Pneumocystis jirovecii pneumonia: a tri-centre cohort study |
| Q42099531 | Clinical evaluation of a (1,3)-beta-D-glucan assay for presumptive diagnosis of Pneumocystis jiroveci pneumonia in immunocompromised patients. |
| Q45420072 | Clinical indicators of Pneumocystis jiroveci pneumonia (PCP) in South African children infected with the human immunodeficiency virus |
| Q51870744 | Clinical outcome and predictors of survival in patients with pneumocystis jirovecii pneumonia--results of a tertiary referral centre. |
| Q82824759 | Clinical parameters and outcomes of Pneumocystis jiroveci pneumonia in non-HIV/AIDS patients |
| Q40437011 | Clinical picture of Pneumocystis jiroveci pneumonia in cancer patients |
| Q35066659 | Clinical relevance of multiple single-nucleotide polymorphisms in Pneumocystis jirovecii Pneumonia: development of a multiplex PCR-single-base-extension methodology. |
| Q37214093 | Clinical significance and phylogenetic relationship of novel Australian Pneumocystis jirovecii genotypes |
| Q44954765 | Clinical significance of Pneumocystis jiroveci in patients with active tuberculosis. |
| Q92574153 | Clinical significance of Pneumocystis jirovecii DNA detection by real-time PCR in hematological patient respiratory specimens |
| Q33690687 | Clinical significance of positive Pneumocystis jirovecii polymerase chain reaction in non-human immunodeficiency virus immunocompromised patients in a real practice |
| Q35689165 | Clinical significance of quantifying Pneumocystis jirovecii DNA by using real-time PCR in bronchoalveolar lavage fluid from immunocompromised patients |
| Q45105852 | Clinical utility of serum beta-D-glucan and KL-6 levels in Pneumocystis jirovecii pneumonia |
| Q54238548 | Clinical, Diagnostic, and Treatment Disparities between HIV-Infected and Non-HIV-Infected Immunocompromised Patients with Pneumocystis jirovecii Pneumonia. |
| Q45142578 | Cloning of the Pneumocystis jirovecii trifunctional FAS gene and complementation of its DHPS activity in Escherichia coli |
| Q35225474 | Co-infection of Mycobacterium tuberculosis and Pneumocystis jirovecii in the Iranian Patients With Human Immunodeficiency Virus |
| Q91884613 | Co-infection of Pneumocystis jirovecii and Aspergillus in a patient with idiopathic thrombocytopenic purpura |
| Q44468811 | Co-infection with Mycobacterium tuberculosis and Pneumocystis jiroveci in a patient without HIV infection |
| Q84958979 | Co-infection with invasive pulmonary aspergillosis and Pneumocystis jirovecii pneumonia after corticosteroid therapy |
| Q85216395 | Coinfection of Pneumocystis jiroveci pneumonia and pulmonary tuberculosis in a non-HIV-infected patient |
| Q44357778 | Coinfection of Pneumocystis jirovecii and invasive pulmonary aspergillosis in an immunocompromised patient: a diagnostic challenge. |
| Q80861138 | Coinfection of invasive pulmonary aspergillosis and pneumocystis jiroveci pneumonia in a non-HIV patient |
| Q93350224 | Coinfection of pneumocystis jiroveci pneumonia and pulmonary aspergillosis in a non-HIV-infected patient |
| Q40900698 | Coinfection with Mycobacterium tuberculosis and Pneumocystis Jirovecii in immunocompetent young woman |
| Q40328132 | Coinfection with Pneumocystis jirovecii and Mycobacterium tuberculosis in a patient with AIDS: a first report in Japan |
| Q58034679 | Colonisation with Pneumocystis jirovecii in Australian infants |
| Q56951717 | Colonization Density of the Upper Respiratory Tract as a Predictor of Pneumonia-Haemophilus influenzae, Moraxella catarrhalis, Staphylococcus aureus, and Pneumocystis jirovecii |
| Q35940586 | Colonization by Pneumocystis jirovecii and its role in disease |
| Q90219920 | Colonization by Pneumocystis jirovecii in patients with chronic obstructive pulmonary disease: association with exacerbations and lung function status |
| Q35266301 | Colonization of Pneumocystis jirovecii in Chronic Obstructive Pulmonary Disease (COPD) patients and the rate of Pneumocystis pneumonia in Iranian non-HIV(+) immunocompromised patients |
| Q64892374 | Colonization of Pneumocystis jirovecii in Patients Who Received and not Received Corticosteroids Admitted to the Intensive Care Unit: Airborne Transmission Approach. |
| Q50037034 | Combination of Echinocandins and Trimethoprim/Sulfamethoxazole for the Treatment of Pneumocystis jiroveci Pneumonia After Heart Transplantation |
| Q38191294 | Combination of caspofungin and low-dose trimethoprim/sulfamethoxazole for the treatment of severe Pneumocystis jirovecii pneumonia in renal transplant recipients |
| Q93174588 | Combination of β-(1, 3)-D-glucan testing in serum and qPCR in nasopharyngeal aspirate for facilitated diagnosis of Pneumocystis jirovecii pneumonia |
| Q37264267 | Combined quantification of pulmonary Pneumocystis jirovecii DNA and serum (1->3)-β-D-glucan for differential diagnosis of pneumocystis pneumonia and Pneumocystis colonization |
| Q53538643 | Combined trimethoprim and caspofungin treatment for severe Pneumocystis jiroveci pneumonia in a five year old boy with acute lymphoblastic leukemia. |
| Q89912263 | Comment on: Pneumocystis jirovecii pneumonia: still a concern in patients with haematological malignancies and stem cell transplant recipients |
| Q40447311 | Comment on: Pneumocystis jirovecii pneumonia: still a concern in patients with haematological malignancies and stem cell transplant recipients. |
| Q61711286 | Comparación de las características clínicas y pronósticas de la neumonía por Pneumocystis jiroveci en pacientes con y sin infección por el virus de la inmunodeficiencia humana |
| Q64935132 | Comparative Analysis of the Wako β-Glucan Test and the Fungitell Assay for Diagnosis of Candidemia and Pneumocystis jirovecii Pneumonia. |
| Q93088250 | Comparative Evaluation Between the RealStar Pneumocystis jirovecii PCR Kit and the AmpliSens Pneumocystis jirovecii (carinii)-FRT PCR Kit for Detecting P. jirovecii in Non-HIV Immunocompromised Patients |
| Q34154706 | Comparative genomics suggests that the human pathogenic fungus Pneumocystis jirovecii acquired obligate biotrophy through gene loss |
| Q54714750 | Comparison between real-time PCR, conventional PCR and different staining techniques for diagnosing Pneumocystis jiroveci pneumonia from bronchoalveolar lavage specimens. |
| Q41391722 | Comparison of 2 real-time PCR assays for diagnosis of Pneumocystis jirovecii pneumonia in human immunodeficiency virus (HIV) and non-HIV immunocompromised patients |
| Q101457490 | Comparison of MultiLocus Sequence Typing (MLST) and Microsatellite Length Polymorphism (MLP) for Pneumocystis jirovecii genotyping |
| Q40351332 | Comparison of a commercial real-time PCR assay, RealCycler® PJIR kit, progenie molecular, to an in-house real-time PCR assay for the diagnosis of Pneumocystis jirovecii infections |
| Q33880693 | Comparison of quantitative real-time PCR and direct immunofluorescence for the detection of Pneumocystis jirovecii |
| Q54567228 | Comparison of single and touchdown PCR protocols for detecting Pneumocystis jirovecii DNA in paraffin-embedded lung tissue samples. |
| Q54352769 | Comparison of the FXG™: RESP (Asp+) real-time PCR assay with direct immunofluorescence and calcofluor white staining for the detection of Pneumocystis jirovecii in respiratory specimens. |
| Q40286274 | Comparison of three cost effective staining methods for detection of Pneumocystis jirovecii |
| Q80199686 | Comparison of trimethoprim-sulfamethoxazole and aerosolized pentamidine for primary prophylaxis of Pneumocystis jiroveci pneumonia in immunocompromised patients with connective tissue disease |
| Q40320640 | Complication of Pneumocystis jiroveci pneumonia |
| Q46741885 | Complications related to dapsone use for Pneumocystis jirovecii pneumonia prophylaxis in solid organ transplant recipients |
| Q43968983 | Concerns regarding data supporting recent Pneumocystis jirovecii prophylaxis guidelines |
| Q47646116 | Concurrent Pneumocystis jirovecii and pulmonary histoplasmosis in an undiagnosed HIV patient. |
| Q37632313 | Congenital rubella pneumonitis complicated by Pneumocystis jiroveci infection with positive long term respiratory outcome: a case report and literature review. |
| Q101214992 | Consensus Multilocus Sequence Typing Scheme for Pneumocystis jirovecii |
| Q38284466 | Consensus guidelines for diagnosis, prophylaxis and management of Pneumocystis jirovecii pneumonia in patients with haematological and solid malignancies, 2014. |
| Q37246773 | Copy Number Variation of Mitochondrial DNA Genes in Pneumocystis jirovecii According to the Fungal Load in BAL Specimens. |
| Q96164304 | Coronavirus disease 2019 and Pneumocystis jirovecii pneumonia: a diagnostic dilemma in HIV |
| Q89414696 | Correction to: Late-onset Pneumocystis jirovecii pneumonia (PJP) in patients with ANCA-associated vasculitis |
| Q96766737 | Correction to: Late-onset Pneumocystis jirovecii pneumonia (PJP) in patients with ANCA-associated vasculitis |
| Q40976721 | Correlation Between Pneumocystis jirovecii Mitochondrial Genotypes and High and Low Fungal Loads Assessed by Single Nucleotide Primer Extension Assay and Quantitative Real-Time PCR. |
| Q42207339 | Correlation between imaging features of Pneumocystis Jiroveci Pneumonitis (PCP), CD(4) (+) T lymphocyte count, and plasma HIV viral load: A study in 50 consecutive AIDS patients |
| Q27653666 | Correlations of Inhibitor Kinetics for Pneumocystis jirovecii and Human Dihydrofolate Reductase with Structural Data for Human Active Site Mutant Enzyme Complexes † ‡ |
| Q89248736 | Corrigendum to "Caspofungin salvage therapy in Pneumocystis jirovecii pneumonia" [J Microbiol Immunol Infect (2016)] pii: S1684-1182(16)30029-9. [Epub ahead of print] |
| Q60520634 | Corrigendum to: Lethal Pneumocystis jiroveci pneumonia 24 Years After Kidney Transplantation [Published in Nephro Urol Mon. 2014 March; 6(2): e13605. DOI: 10.5812/numonthly.13605] |
| Q61915282 | Corticosteroids Therapy and Pneumocystis Jirovecii Pneumonia (PCP) |
| Q35692811 | Cost-effectiveness of Prophylaxis Against Pneumocystis jiroveci Pneumonia in Patients with Crohn's Disease. |
| Q97868778 | Critical appraisal of the quality and content of clinical practice guidelines for pneumocystis jiroveci pneumonia (PJP) prophylaxis using the AGREE II instrument |
| Q35146521 | Critical importance of long-term adherence to care in HIV infected patients in the cART era: new insights from Pneumocystis jirovecii pneumonia cases over 2004-2011 in the FHDH-ANRS CO4 cohort |
| Q90609953 | Crossing a New Threshold: Use of Elevated (1,3)-β-d- Glucan Levels to Distinguish Causation From Colonization in Pneumocystis jirovecii Polymerase Chain Reaction-Positive Cancer Patients |
| Q44815062 | Current epidemiology of Pneumocystis jirovecii infections |
| Q41124208 | Cystic lung lesions revealing a Pneumocystis jirovecii and Aspergillus flavus co-infection in an HIV-infected patient |
| Q90030590 | Cytomegaloviral or Pneumocystis Jiroveci Pneumonia Increases Mortality in Systemic Lupus Erythematosus Patients with Pulmonary Hemorrhage: Evidence from Bronchoalveolar Lavage Fluid |
| Q54567277 | DHPS-mutated isolates of Pneumocystis jirovecii from HIV-infected individuals: analysis of related ITS genotypes. |
| Q127071456 | DIAGNOSTIC AND MANAGEMENT CHALLENGES IN A CASE OF INSIDIOUS PNEUMOCYSTIS JIROVECII PNEUMONIA (PCP) WITH RESULTANT FULMINANT LUNG DESTRUCTION IN A NON-HIV IMMUNOCOMPROMISED PATIENT |
| Q128101397 | DRUGS, HYPERSENSITIVITY REACTIONS, AND DESENSITIZATIONS IN HIV PATIENT WITH TB AND PNEUMOCYSTIS JIROVECI PNEUMONIA INFECTIONS |
| Q97588432 | Dapsone for Pneumocystis jirovecii pneumonia prophylaxis - applying theory to clinical practice with a focus on drug interactions |
| Q90379276 | Dapsone safety in hematology patients: Pathways to optimizing Pneumocystis jirovecii pneumonia prophylaxis in hematology malignancy and transplant recipients |
| Q36492975 | De novo assembly of the Pneumocystis jirovecii genome from a single bronchoalveolar lavage fluid specimen from a patient. |
| Q104573975 | Deficiency of mannose-binding lectin is a risk of Pneumocystis jirovecii pneumonia in a natural history cohort of people living with HIV/AIDS in Northern Thailand |
| Q44736825 | Definitive structural identities of Pneumocystis jirovecii sterols |
| Q51043096 | Degree and frequency of inhibition in a routine real-time PCR detecting Pneumocystis jirovecii for the diagnosis of Pneumocystis pneumonia in Turkey. |
| Q64768796 | Delayed Strongyloides stercoralis hyperinfection syndrome in a renal transplant patient with Pneumocystis jirovecii pneumonia receiving high-dose corticosteroids |
| Q129325674 | Denosumab in a pediatric kidney transplant recipient with late, resistant hypercalcemia secondary to Pneumocystis jirovecii pneumonia |
| Q93118852 | Detección y genotipificación de Pneumocystis jirovecii en muestras de pacientes mexicanos VIH positivos y negativos |
| Q41039877 | Detection of Pneumocystis jiroveci in respiratory specimens by four staining methods |
| Q41289970 | Detection of Pneumocystis jirovecii and Aspergillus spp. DNa in bronchoalveolar lavage fluids by commercial real-time PCr assays: comparison with conventional diagnostic tests |
| Q36933191 | Detection of Pneumocystis jirovecii by Quantitative PCR To Differentiate Colonization and Pneumonia in Immunocompromised HIV-Positive and HIV-Negative Patients |
| Q40327238 | Detection of Pneumocystis jirovecii by nested PCR in HIV-negative patients with pulmonary disease. |
| Q91705894 | Detection of Pneumocystis jirovecii by quantitative real-time PCR in oral rinses from Pneumocystis pneumonia asymptomatic human immunodeficiency virus patients |
| Q46160365 | Detection of Pneumocystis jirovecii by two staining methods and two quantitative PCR assays |
| Q38954181 | Detection of Pneumocystis jirovecii dihydropteroate synthase polymorphisms in patients with Pneumocystis pneumonia. |
| Q36328442 | Detection of Pneumocystis jirovecii in oral wash from immunosuppressed patients as a diagnostic tool |
| Q96583407 | Detection of anti-Pneumocystis jirovecii antibodies in human serum using a recombinant synthetic multi-epitope kexin-based antigen |
| Q51720352 | Deterioration of the immune response induced by sulfamethoxazole-trimethoprim in a rheumatoid arthritis patient with Pneumocystis jirovecii pneumonia. |
| Q46615607 | Development and Evaluation of a Real-Time PCR Assay for Detection of Pneumocystis jirovecii on the Fully Automated BD MAX Platform |
| Q100697862 | Development and evaluation of a fully automated molecular assay targeting the mitochondrial small subunit rRNA gene for the detection of Pneumocystis jirovecii in bronchoalveolar lavage fluid specimens |
| Q80555802 | Development and evaluation of a real-time PCR assay for detection of Pneumocystis jiroveci |
| Q56403277 | Development and evaluation of a real-time PCR assay for detection of Pneumocystis jirovecii DNA in bronchoalveolar lavage fluid of HIV-infected patients |
| Q36971085 | Development and evaluation of a real-time PCR assay for detection of Pneumocystis jirovecii on the fully automated BD MAX platform |
| Q36277378 | Development and validation of a Pneumocystis jirovecii real-time polymerase chain reaction assay for diagnosis of Pneumocystis pneumonia |
| Q57680610 | Development of a Real-Time PCR-Based Fluorescence Assay for Rapid Detection of Point Mutations in Pneumocystis jirovecii Dihydropteroate Synthase Gene |
| Q90780236 | Development of a fully automated PCR assay for the detection of Pneumocystis jirovecii using the GENECUBE system |
| Q94651981 | Diagnosing Pneumocystis jirovecii pneumonia: A review of current methods and novel approaches |
| Q40297079 | Diagnosis and management of Pneumocystis jirovecii infection |
| Q91838335 | Diagnosis and treatment of Pneumocystis jirovecii pneumonia in HIV-infected or non-HIV-infected patients-difficulties in diagnosis and adverse effects of trimethoprim-sulfamethoxazole |
| Q130104725 | Diagnosis dan Tata Laksana Pneumocystis Carinii Pneumonia (PCP)/Pneumocystis Jirovecii Pneumonia pada pasien HIV: Sebuah Laporan Kasus |
| Q92124560 | Diagnosis of Pneumocystis jirovecii Pneumonia in Pediatric Patients in Serbia, Greece, and Romania. Current Status and Challenges for Collaboration |
| Q35035794 | Diagnosis of Pneumocystis jirovecii pneumonia in immunocompromised patients by real-time PCR: a 4-year prospective study |
| Q42700853 | Diagnosis of Pneumocystis jirovecii pneumonia with serum cell-free DNA in non-HIV-infected immunocompromised patients |
| Q100449589 | Diagnostic Performance of Bronchoalveolar Lavage (1,3)-β-d-Glucan Assay for Pneumocystis jirovecii Pneumonia |
| Q95940416 | Diagnostic accuracy of (1→3)-β-D-glucan to predict Pneumocystis jirovecii pneumonia in non-HIV-infected patients |
| Q96033742 | Diagnostic accuracy of serum (1-3)-β-D-Glucan for Pneumocystis jirovecii pneumonia: a systematic review and meta-analysis |
| Q35668212 | Diagnostic accuracy of serum 1,3-β-D-glucan for pneumocystis jiroveci pneumonia, invasive candidiasis, and invasive aspergillosis: systematic review and meta-analysis. |
| Q104585129 | Diagnostic evaluation of serum (1, 3)-β-d-glucan levels using the Fungitec G-Test MK kit for Pneumocystis jirovecii pneumonia (PCP) in non-HIV patients |
| Q54401177 | Diagnostic of Pneumocystis jirovecii pneumonia in a non HIV patient |
| Q47114916 | Diagnostic performance of the (1-3)-β-D-glucan assay in patients with Pneumocystis jirovecii compared with those with candidiasis, aspergillosis, mucormycosis, and tuberculosis, and healthy volunteers |
| Q48068990 | Diagnostic significance of nested polymerase chain reaction for sensitive detection of Pneumocystis jirovecii in respiratory clinical specimens |
| Q42229132 | Diagnostic value of direct fluorescence antibody staining for detecting Pneumocystis jirovecii in expectorated sputum from patients with HIV infection |
| Q61653152 | Diagnóstico microscópico de neumonía por Pneumocystis jirovecii en muestras de lavado broncoalveolar y lavado orofaríngeo de pacientes inmunocomprometidos con neumonía |
| Q44866140 | Differences in the clinical characteristics of Pneumocystis jirovecii pneumonia in immunocompromized patients with and without HIV infection |
| Q43092145 | Difficulties in diagnosing severe Pneumocystis jiroveci pneumonia after rituximab therapy for steroid-dependent nephrotic syndrome |
| Q41723856 | Diffuse alveolar hemorrhage associated with Henoch-Schönlein purpura and Pneumocystis jirovecii infection: A case report |
| Q39218342 | Diffusion of Pneumocystis jirovecii in the surrounding air of patients with Pneumocystis colonization: frequency and putative risk factors |
| Q83254089 | Dihydropteroate synthase (DHPS) gene mutation study in HIV-Infected Indian patients with Pneumocystis jirovecii pneumonia |
| Q38954192 | Dihydropteroate synthase (DHPS) genotyping by PCR-RFLP analysis of Pneumocystis jirovecii repeated isolates from HIV-infected patients: a preliminary study |
| Q42012011 | Dihydropteroate synthase and novel dihydrofolate reductase gene mutations in strains of Pneumocystis jirovecii from South Africa |
| Q41516189 | Dihydropteroate synthase gene mutation rates in Pneumocystis jirovecii strains obtained from Iranian HIV-positive and non-HIV-positive patients. |
| Q83934204 | Dihydropteroate synthase gene mutations in Pneumocystis jiroveci strains isolated from immunocompromised patients |
| Q35124499 | Dihydropteroate synthase mutations in Pneumocystis jiroveci can affect sulfamethoxazole resistance in a Saccharomyces cerevisiae model |
| Q26829541 | Discontinuation of Pneumocystis jirovecii pneumonia prophylaxis with CD4 count <200 cells/µL and virologic suppression: a systematic review |
| Q35769862 | Discontinuing Pneumocystis jirovecii Pneumonia Prophylaxis in HIV-Infected Patients With a CD4 Cell Count <200 cells/mm3. |
| Q92751605 | Disseminated Pneumocystis jirovecii Infection with Osteomyelitis in a Patient with CTLA-4 Haploinsufficiency |
| Q35173351 | Distribution of Pneumocystis jirovecii in lungs from colonized COPD patients |
| Q38680375 | Diversity of Pneumocystis jirovecii Across Europe: A Multicentre Observational Study |
| Q36927964 | Diversity of Pneumocystis jirovecii during Infection Revealed by Ultra-Deep Pyrosequencing |
| Q95604528 | Do COVID-19 patients admitted to the ICU require anti-Pneumocystis jirovecii prophylaxis? |
| Q36373506 | Dual infection with Mycobacterium tuberculosis and Pneumocystis jiroveci Lymphadenitis in a Patient with HIV infection: case report and review of the literature |
| Q80824108 | Dynamic colonisation by different Pneumocystis jirovecii genotypes in cystic fibrosis patients |
| Q38934525 | ECIL guidelines for preventing Pneumocystis jirovecii pneumonia in patients with haematological malignancies and stem cell transplant recipients |
| Q30248345 | ECIL guidelines for the diagnosis of Pneumocystis jirovecii pneumonia in patients with haematological malignancies and stem cell transplant recipients |
| Q38934528 | ECIL guidelines for treatment of Pneumocystis jirovecii pneumonia in non-HIV-infected haematology patients |
| Q40196669 | Early Acquisition of Pneumocystis jirovecii Colonization and Potential Association With Respiratory Distress Syndrome in Preterm Newborn Infants. |
| Q37055188 | Early predictors of mortality from Pneumocystis jirovecii pneumonia in HIV-infected patients: 1985-2006. |
| Q84360822 | Early recurrence of Pneumocystis jiroveci pneumonia in two HIV-infected patients: linking infection relapse and immune reconstitution syndrome |
| Q40350762 | Early use of corticosteroids in infants with a clinical diagnosis of Pneumocystis jiroveci pneumonia in Malawi: a double-blind, randomised clinical trial. |
| Q83783345 | Effective Pneumocystis jiroveci pneumonia prophylaxis with trimethoprim-sulfamethoxazole once a day twice a week |
| Q91043765 | Effectiveness and safety of lower dose sulfamethoxazole/trimethoprim therapy for Pneumocystis jirovecii pneumonia in patients with systemic rheumatic diseases: A retrospective multicenter study |
| Q41062845 | Effects of Sulfamethoxazole-Trimethoprim on Airway Colonization with Pneumocystis jirovecii |
| Q38686315 | Effects of clinical and environmental factors on bronchoalveolar antibody responses to Pneumocystis jirovecii: A prospective cohort study of HIV+ patients |
| Q91316400 | Efficacies of atovaquone, pentamidine, and trimethoprim/sulfamethoxazole for the prevention of Pneumocystis jirovecii pneumonia in patients with connective tissue diseases |
| Q40318953 | Efficacy and Safety of Dapsone Versus Trimethoprim/Sulfamethoxazol for Pneumocystis Jiroveci Prophylaxis in Children With Acute Lymphoblastic Leukemia With a Background of Ethnic Neutropenia |
| Q85752145 | Efficacy and tolerability of intravenous pentamidine isethionate for Pneumocystis jiroveci prophylaxis in a pediatric oncology population |
| Q60304978 | Efficacy of caspofungin combined with clindamycin for Pneumocystis jirovecii pneumonia in a systemic lupus erythematosus patient: A case report and literature review |
| Q38586686 | Efficacy of once-weekly dapsone dosing for Pneumocystis jirovecii pneumonia prophylaxis post transplantation |
| Q42849189 | Elevated serum beta-D-glucan levels in immunocompromised children with clinical suspicion for Pneumocystis jirovecii pneumonia |
| Q35880630 | Enzyme-linked immunosorbent assay and serologic responses to Pneumocystis jiroveci |
| Q92658216 | Epidemiologic Trends and Clinical Features of Pneumocystis jirovecii Pneumonia in Non-HIV Patients in a Tertiary-Care Hospital in Korea over a 15-Year-Period |
| Q36834775 | Epidemiological Outbreaks of Pneumocystis jirovecii Pneumonia Are Not Limited to Kidney Transplant Recipients: Genotyping Confirms Common Source of Transmission in a Liver Transplantation Unit |
| Q37809044 | Epidemiology and clinical relevanceofPneumocystis jiroveciiFrenkel, 1976 dihydropteroate synthase gene mutations |
| Q28082149 | Epidemiology and long-term survival in HIV-infected patients with Pneumocystis jirovecii pneumonia in the HAART era: experience in a university hospital and review of the literature |
| Q92678723 | Epidemiology and risk factors associated with Pneumocystis jirovecii pneumonia in kidney transplant recipients after 6-month trimethoprim-sulfamethoxazole prophylaxis: A case-control study |
| Q96155644 | Epidemiology of Pneumocystis jirovecii Pneumonia and (Non-)use of Prophylaxis |
| Q42387003 | Erratum: Pneumocystis jirovecii pneumonia in pediatric patients: an analysis of 15 confirmed consecutive cases during 14 years |
| Q47106426 | Etymologia: Pneumocystis jirovecii |
| Q129522306 | Evaluation of DNA extraction by boiling method for PCRbaseddetection of Pneumocystis jirovecii in sputumsamples from immunocompromised patients |
| Q40872690 | Evaluation of Loop-Mediated Isothermal Amplification Assay for the Detection of Pneumocystis jirovecii in Immunocompromised Patients |
| Q45811103 | Evaluation of PCR based DNA sequencing targeting mitochondrial larger subunit (mtLSU) region for the rapid detection of Pneumocystis jirovecii in sputum from HIV positive patients |
| Q26865669 | Evaluation of PCR in bronchoalveolar lavage fluid for diagnosis of Pneumocystis jirovecii pneumonia: a bivariate meta-analysis and systematic review |
| Q90206621 | Evaluation of Three Different Laboratory Methods for Identification of Pneumocystis jirovecii Pneumonia (PCP) among HIV Positive Asymptomatic Prisoners |
| Q44399654 | Evaluation of Toluidine Blue O staining for the diagnosis of Pneumocystis jiroveci in expectorated sputum sample and bronchoalveolar lavage from HIV-infected patients in a tertiary care referral center in Ethiopia |
| Q59349040 | Evaluation of a Turbidimetric β-d-Glucan Test for Detection of Pneumocystis jirovecii Pneumonia |
| Q40479086 | Evaluation of a new commercial real-time PCR assay for diagnosis of Pneumocystis jirovecii pneumonia and identification of dihydropteroate synthase (DHPS) mutations. |
| Q54170367 | Evaluation of different real time PCRs for the detection of Pneumocystis jirovecii DNA in formalin-fixed paraffin-embedded bronchoalveolar lavage samples. |
| Q39069388 | Evaluation of quantitative FTD-Pneumocystis jirovecii kit for Pneumocystis infection diagnosis. |
| Q42428196 | Evaluation of sensitivity of multiplex PCR for Detection of Mycobacterium tuberculosis and Pneumocystis jirovecii in clinical samples |
| Q99556999 | Evaluation of the Amplex eazyplex® loop-mediated isothermal amplification assay for rapid diagnosis of Pneumocystis jirovecii pneumonia |
| Q125777915 | Evaluation of the Performance of a Multiplex Real-Time PCR Assay for the Identification of Aspergillus, Cryptococcus neoformans, and Pneumocystis jirovecii Simultaneously from Sputum in Multicenter |
| Q38784835 | Evaluation of the automated Becton Dickinson MAX real-time PCR platform for detection of Pneumocystis jirovecii. |
| Q43538924 | Evaluation of the current management protocols for prophylaxis against Pneumocystis jiroveci pneumonia and other opportunistic infections in patients living with HIV/AIDS. |
| Q84383700 | Evaluation of the frequency of Pneumocystis jirovecii occurrence in a group of children hospitalized for acute respiratory infections |
| Q89650080 | Evaluation of the performance of DiaSorin molecular Pneumocystis jirovecii-CMV multiplex real-time PCR assay from bronchoalveolar lavage samples |
| Q37385491 | Evidence for high prevalence of Pneumocystis jirovecii exposure among Cameroonians. |
| Q36882501 | Expression of Pneumocystis jirovecii major surface glycoprotein in Saccharomyces cerevisiae |
| Q96610316 | Expression pattern of the Pneumocystis jirovecii major surface glycoprotein superfamily in patients with pneumonia |
| Q48643572 | Extra-pulmonary Pneumocystis jiroveci infection: a case report |
| Q54027179 | Extracorporeal life support for immune reconstitution inflammatory syndrome in HIV patients with Pneumocystis jirovecii pneumonia. |
| Q44381675 | Extracorporeal membrane oxygenation as treatment for acute respiratory failure and subsequent pneumothorax caused by Pneumocystis jirovecii pneumonia in a kidney transplant recipient |
| Q91284195 | Extracorporeal membrane oxygenation in Pneumocystis jirovecii pneumonia: outcome in HIV and non-HIV patients |
| Q37634160 | Fact or fiction: does the non-HIV/AIDS immunosuppressed patient need Pneumocystis jiroveci pneumonia prophylaxis? An updated literature review |
| Q57255600 | Faculty of 1000 evaluation for De novo assembly of the Pneumocystis jirovecii genome from a single bronchoalveolar lavage fluid specimen from a patient |
| Q44850151 | Failure of low-dose atovaquone prophylaxis against Pneumocystis jiroveci infection in transplant recipients |
| Q60997955 | Falla de la profilaxis con cotrimoxazol para la neumonía por Pneumocystis jiroveci con el uso concomitante de leucovorina: Reporte de un caso |
| Q92120238 | Fatal Pneumocystis jirovecii Pneumonia in a Patient on Adalimumab: A Case Report |
| Q54366957 | Fatal Pneumocystis jirovecii pneumonia following immunosuppressive therapy with rituximab and prednisolone for posterior scleritis. |
| Q40141721 | Fatal Pneumocystis jirovecii pneumonia in a HIV-negative adult |
| Q93042132 | Fatal Pneumocystis jirovecii pneumonia in a non-immunocompromised patient with alcohol-related liver cirrhosis |
| Q47983751 | Fatal infection of Pneumocystis jiroveci pneumonia in a pemphigus patient treated with rituximab |
| Q43273781 | Fatal pneumocystis jiroveci pneumonia in ABVD-treated Hodgkin lymphoma patients |
| Q46559544 | Fatal pneumocystis jirovecii pneumonia in a case of ectopic Cushing's syndrome due to neuroendocrine carcinoma of the kidney |
| Q30965154 | First data on Pneumocystis jirovecii colonization in patients with respiratory diseases in North Lebanon |
| Q44166623 | FlindersTechnology Associates (FTA) filter paper-based DNA extraction with polymerase chain reaction (PCR) for detection of Pneumocystis jirovecii from respiratory specimens of immunocompromised patients. |
| Q54218678 | Frequency of Pneumocystis jirovecii in sputum from HIV and TB patients in Namibia. |
| Q42090155 | Frequent in vitro recombination in internal transcribed spacers 1 and 2 during genotyping of Pneumocystis jirovecii |
| Q35385810 | Functional characterization of the Pneumocystis jirovecii potential drug targets dhfs and abz2 involved in folate biosynthesis |
| Q91084484 | Genetic Polymorphisms of Superoxide Dismutase Locus of Pneumocystis jirovecii in Spanish Population |
| Q44480121 | Genetic characterization of UCS region of Pneumocystis jirovecii and construction of allelic profiles of Indian isolates based on sequence typing at three regions |
| Q38995797 | Genetic characterization of the UCS and Kex1 loci of Pneumocystis jirovecii. |
| Q38954170 | Genetic characterization of the dihydrofolate reductase gene of Pneumocystis jirovecii isolates from Portugal |
| Q89543993 | Genetic diversity of Pneumocystis jirovecii from a cluster of cases of pneumonia in renal transplant patients: Cross-sectional study |
| Q36542948 | Genetic diversity of Pneumocystis jirovecii in Thailand |
| Q39263263 | Genetic diversity of Pneumocystis jirovecii in colonized Cuban infants and toddlers |
| Q34501109 | Genetic diversity of Pneumocystis jirovecii strains based on sequence variation of different DNA region |
| Q34774564 | Genotypes at the internal transcribed spacers of the nuclear rRNA operon of Pneumocystis jiroveci in nonimmunosuppressed infants without severe pneumonia |
| Q40345286 | Genotypes of Pneumocystis jiroveci isolates obtained in Harare, Zimbabwe, and London, United Kingdom |
| Q42868717 | Genotypic study of Pneumocystis jirovecii in human immunodeficiency virus-positive patients in Thailand |
| Q35537873 | Genotypic variation in Pneumocystis jirovecii isolates in Britain |
| Q54415771 | Genotypic variation of Pneumocystis jirovecii isolates in India based on sequence diversity at mitochondrial large subunit rRNA. |
| Q128528414 | Genotyping Pneumocystis jirovecii: Impacting Our Understanding of Interhuman Transmission |
| Q40762795 | Genotyping and coalescent phylogenetic analysis of Pneumocystis jiroveci from South Africa. |
| Q46047407 | Genotyping and phylogenetic analysis of Pneumocystis jirovecii isolates from India |
| Q36844674 | Genotyping of Pneumocystis jiroveci pneumonia in Italian AIDS patients. Clinical outcome is influenced by dihydropteroate synthase and not by internal transcribed spacer genotype |
| Q92657482 | Genotyping of Pneumocystis jirovecii by Use of a New Simplified Nomenclature System Based on the Internal Transcribed Spacer Regions and 5.8S rRNA Gene of the rRNA Operon |
| Q47329930 | Genotyping of Pneumocystis jirovecii in colonized patients with various pulmonary diseases |
| Q43453614 | Genotyping of Pneumocystis jirovecii isolates from Chinese HIV-infected patients based on nucleotide sequence variations in the internal transcribed spacer regions of rRNA genes |
| Q39498449 | Genotyping of Pneumocystis jirovecii isolates from human immunodeficiency virus-negative patients in China |
| Q91796913 | Genotyping of Pneumocystis jirovecii isolates obtained from clinical samples by multilocus sequencing: a molecular epidemiology study conducted in Turkey |
| Q61681949 | Geographical Variation in the Prevalence of Pneumocystis jirovecii Dihydropteroate Synthase Mutations Within Western Europe |
| Q37396829 | Geographical variation in serological responses to recombinant Pneumocystis jirovecii major surface glycoprotein antigens |
| Q92432743 | Gomori Methenamine Silver Stain on Bronchoalveolar Lavage Fluid Is Poorly Sensitive for Diagnosis of Pneumocystis jiroveci Pneumonia in HIV-Negative Immunocompromised Patients and May Lead to Missed or Delayed Diagnoses |
| Q37634515 | Good outcome with trimethoprim 10 mg/kg/day-sulfamethoxazole 50 mg/kg/day for Pneumocystis jirovecii pneumonia in HIV infected patients |
| Q36736031 | Granulomatous Pneumocystis jiroveci Pneumonia in a patient with chronic lymphocytic leukemia: a literature review and hypothesis on pathogenesis |
| Q40707012 | Granulomatous Pneumocystis jiroveci pneumonia associated with immune reconstituted HIV. |
| Q37639010 | Granulomatous Pneumocystis jiroveci pneumonia in a patient with diffuse large B-cell lymphoma: case report and review of the literature. |
| Q100567270 | Granulomatous Pneumocystis jirovecii mimics pulmonary metastasis in rectal cancer |
| Q129021499 | Granulomatous Pulmonary Pneumocystis jirovecii in patients with solid and lymphoproliferative neoplasms: Clinicopathologic characterization of 9 cases |
| Q41139462 | Granulomatous Reaction to Pneumocystis jirovecii Diagnosed in a Bronchoalveolar Lavage: A Case Report. |
| Q34111681 | Granulomatous reaction to pneumocystis jirovecii: clinicopathologic review of 20 cases. |
| Q89426706 | Guidelines for the Prophylaxis of Pneumocystis jirovecii Pneumonia (PJP) in Children With Solid Tumors |
| Q45833085 | HCP-17RETROSPECTIVE ANALYSIS OF PNEUMOCYSTIS JIROVECI IN BRAIN TUMOR PATIENTS. |
| Q98569807 | HIV and Pneumocystis Jiroveci Pneumonia (PJP) Managed With Extracorporeal Membrane Oxygenation (ECMO) |
| Q42650149 | HIV-related Pneumocystis jirovecii pneumonia managed with caspofungin and veno-venous extracorporeal membrane oxygenation rescue therapy |
| Q53237068 | HRCT-features of Pneumocystis jiroveci pneumonia and their evolution before and after treatment in non-HIV immunocompromised patients. |
| Q35683138 | HTLV-1-associated adult T cell leukemia lymphoma presenting as granulomatous pneumocystis jiroveci pneumonia (PJP) and hypercalcemia |
| Q80681557 | Haemophagocytic syndrome associated with Hodgkin lymphoma and Pneumocystis jiroveci pneumonitis |
| Q33836657 | Healthcare worker occupation and immune response to Pneumocystis jirovecii |
| Q40250858 | Herpes Simplex Virus, Cytomegalovirus, and Pneumocystis jiroveci Pneumonia in a Treatment-Naive HIV-Positive Patient with Pulmonary Alveolar Proteinosis: Case Report |
| Q39012791 | High Pneumocystis jirovecii colonization rate among haemodialysis patients |
| Q37612910 | High Prevalence of Pneumocystis jirovecii Dihydropteroate Synthase Gene Mutations in Patients with a First Episode of Pneumocystis Pneumonia in Santiago, Chile, and Clinical Response to Trimethoprim-Sulfamethoxazole Therapy. |
| Q92338580 | High incidence of Pneumocystis jirovecii pneumonia in allogeneic hematopoietic cell transplant recipients in the modern era |
| Q43109656 | High incidence of Pneumocystis jirovecii pneumonia in patients receiving biweekly rituximab and cyclophosphamide, adriamycin, vincristine, and prednisone |
| Q92819183 | High initial (1, 3) Beta-d-Glucan concentration may be a predictor of satisfactory response of c aspofungin combined with TMP/SMZ for HIV-negative patients with moderate to severe Pneumocystis jirovecii pneumonia |
| Q54395598 | High prevalence of Pneumocystis jiroveci colonization among young HIV-infected patients. |
| Q39117679 | High prevalence of Pneumocystis jirovecii colonization among HIV-positive patients in southern Brazil |
| Q39012809 | High prevalence of Pneumocystis jirovecii colonization among patients with autoimmune inflammatory diseases and corticosteroid therapy. |
| Q54331982 | High prevalence of Pneumocystis jirovecii colonization in Brazilian cystic fibrosis patients. |
| Q40301440 | High prevalence of Pneumocystis jirovecii pneumonia among Mozambican children <5 years of age admitted to hospital with clinical severe pneumonia |
| Q33909311 | High prevalence of dihydropteroate synthase mutations in Pneumocystis jirovecii isolated from patients with Pneumocystis pneumonia in South Africa |
| Q38472454 | High rates of primary Mycobacterium avium complex and Pneumocystis jiroveci prophylaxis in the United States. |
| Q40044463 | High transient colonization by Pneumocystis jirovecii between mothers and newborn. |
| Q64082420 | High-resolution CT, histopathologic, and clinical features of granulomatous pneumocystis jiroveci pneumonia |
| Q92810871 | Histoplasma capsulatum and Pneumocystis jirovecii coinfection in hospitalized HIV and non-HIV patients from a tertiary care hospital in Mexico |
| Q45355201 | Human herpes virus co-infection is associated with mortality in HIV-negative patients with Pneumocystis jirovecii pneumonia |
| Q90204291 | Humans Are Selectively Exposed to Pneumocystis jirovecii |
| Q35080065 | Humoral immune responses to Pneumocystis jirovecii antigens in HIV-infected and uninfected young children with pneumocystis pneumonia |
| Q47159286 | Hypercalcaemia preceding diagnosis of Pneumocystis jirovecii pneumonia in renal transplant recipients. |
| Q91292987 | Hypercalcemia Heralding Pneumocystis jirovecii Pneumonia in an HIV-Seronegative Patient with Diffuse Cutaneous Systemic Sclerosis |
| Q93017968 | Hypercalcemia associated with Pneumocystis jirovecii pneumonia in renal transplant recipients: case report and literature review |
| Q43129000 | Hypothetical Pneumocystis jirovecii transmission from immunocompetent carriers to infant |
| Q92934483 | IL-4 polymorphism influences susceptibility to Pneumocystis jirovecii pneumonia in HIV-positive patients |
| Q40663515 | IV pentamidine for Pneumocystis jiroveci pneumonia prophylaxis in pediatric allogeneic stem cell transplant patients |
| Q48226445 | Ibrutinib-associated Pneumocystis jirovecii pneumonia. |
| Q39177044 | Identification and Functional Ascertainment of the Pneumocystis jirovecii Potential Drug Targets Gsc1 and Kre6 Involved in Glucan Synthesis. |
| Q120246646 | Identification of Single-Base Mismatches in Pneumocystis jirovecii Isolated from Iranian TB positive Patients by CSGE Heteroduplex |
| Q100953979 | Identification of predictive markers and outcomes of late-onset Pneumocystis jirovecii pneumonia in kidney transplant recipients |
| Q33498640 | Identification of relevant single-nucleotide polymorphisms in Pneumocystis jirovecii: relationship with clinical data |
| Q90454221 | Imaging patterns of Pneumocystis jirovecii pneumonia in HIV-positive and renal transplant patients - a multicentre study |
| Q92250347 | Imatinib-Associated Pneumocystis jirovecii Pneumonia in a Patient With Chronic Myeloid Leukemia |
| Q91294103 | Immediate versus deferred antiretroviral therapy in HIV-infected patients presenting with acute AIDS-defining events (toxoplasmosis, Pneumocystis jirovecii-pneumonia): a prospective, randomized, open-label multicenter study (IDEAL-study) |
| Q99409738 | Immune reconstitution inflammatory syndrome (IRIS) in an HIV-positive patient with Pneumocystis jirovecii pneumonia (PjP) and morbus Kaposi |
| Q47571515 | Immune reconstitution inflammatory syndrome in HIV-infected patients with Pneumocystis jirovecii pneumonia |
| Q40392438 | Immunization with Pneumocystis Cross-Reactive Antigen 1 (Pca1) Protects Mice against Pneumocystis Pneumonia and Generates Antibody to Pneumocystis jirovecii. |
| Q38449198 | Immunocompetent infants as a human reservoir for Pneumocystis jirovecii: rapid screening by non-invasive sampling and real-time PCR at the mitochondrial large subunit rRNA gene |
| Q91009252 | Immunosuppression for Immune Checkpoint-related Toxicity Can Cause Pneumocystis Jirovecii Pneumonia (PJP) in Non-small-cell Lung Cancer (NSCLC): A Report of 2 Cases |
| Q60176850 | Immunosuppressive Treatment and Its Effect on the Occurrence of Pneumocystis jiroveci, Mycoplasma pneumoniae, Chlamydophila pnemoniae, and Legionella pneumophila Infections/Colonizations Among Lung Transplant Recipients |
| Q36297681 | Impact of HIV Infection Status on Interpretation of Quantitative PCR for Detection of Pneumocystis jirovecii |
| Q64891355 | Impact of Pneumocystis jirovecii pneumonia on kidney transplant outcome. |
| Q41638598 | Impact of an intravenous trimethoprim/sulfamethoxazole shortage on treatment outcomes among HIV-infected patients with Pneumocystis jirovecii pneumonia |
| Q127106221 | Impact of the Use of Polymerase Chain Reaction for the Diagnosis and Management of Pneumocystis Jirovecii Pneumoniae in a Retrospective Cohort of Patients with Lymphoid Malignancies |
| Q42262587 | Impaired thymic function and CD4+ T lymphopenia, but not mannose-binding lectin deficiency, are risk factors for Pneumocystis jirovecii pneumonia in kidney transplant recipients |
| Q34085002 | Improved detection of Pneumocystis jirovecii in upper and lower respiratory tract specimens from children with suspected pneumocystis pneumonia using real-time PCR: a prospective study. |
| Q36852863 | Improved detection of Pneumocystis jirovecii infection in a tertiary care reference hospital in India |
| Q36184151 | Improved survival for HIV infected patients with severe Pneumocystis jirovecii pneumonia is independent of highly active antiretroviral therapy |
| Q90870278 | In Search of Clinical Factors that Predict Risk for Pneumocystis jirovecii Pneumonia in Patients without HIV/AIDS |
| Q55413117 | Inability to Culture Pneumocystis jirovecii. |
| Q46152494 | Inappropriate use of steroid and pneumocystis jiroveci pneumonia: report of two cases. |
| Q92618475 | Incidence and risk factors of Pneumocystis jirovecii pneumonia in Korean patients with inflammatory bowel disease |
| Q42204004 | Incidence of Pneumocystis jiroveci pneumonia among groups at risk in HIV-negative patients |
| Q41921482 | Incidence of Pneumocystis jirovecii and Adverse Events Associated With Pneumocystis Prophylaxis in Children Receiving Glucocorticoids. |
| Q38257043 | Incidence of Pneumocystis jirovecii pneumonia after temozolomide for CNS malignancies without prophylaxis |
| Q104793305 | Increased mRNA expression of key cytokines among suspected cases of Pneumocystis jirovecii infection |
| Q40670732 | Increased prevalence of Pneumocystis jirovecii colonisation in acute pulmonary exacerbations of cystic fibrosis |
| Q37429242 | Increased risk of pneumocystis jiroveci pneumonia among patients with inflammatory bowel disease |
| Q58858314 | Increasing Frequency of Pneumocystis jirovecii Pneumonia in Renal Transplant Recipients in the United Kingdom: Clonal Variability, Clusters, and Geographic Location |
| Q43854797 | Induced sputum versus bronchoalveolar lavage in the diagnosis of pneumocystis jiroveci pneumonia in human immunodeficiency virus-positive patients |
| Q54302915 | Infection due to Pneumocystis jirovecii in haemodialysis. |
| Q83970113 | Influence of type of cancer and hematopoietic stem cell transplantation on clinical presentation of Pneumocystis jiroveci pneumonia in cancer patients |
| Q47665239 | Influenza and Pneumocystis jirovecii pneumonia in an allogeneic hematopoietic stem cell transplantation recipient: Coinfection or superinfection? |
| Q30983646 | Infrequent detection of Pneumocystis jirovecii by PCR in oral wash specimens from TB patients with or without HIV and healthy contacts in Tanzania |
| Q84174108 | Inhaled pentamidine for Pneumocystis jiroveci prophylaxis in a heart transplant recipient with allergy for trimethoprim sulfamethoxazole |
| Q64950073 | Inter-Specimen Imbalance of Mitochondrial Gene Copy Numbers Predicts Clustering of Pneumocystis jirovecii Isolates in Distinct Subgroups. |
| Q51935065 | Inter-laboratory comparison of three different real-time PCR assays for the detection of Pneumocystis jiroveci in bronchoalveolar lavage fluid samples. |
| Q54421176 | Interhuman transmission as a potential key parameter for geographical variation in the prevalence of Pneumocystis jirovecii dihydropteroate synthase mutations. |
| Q82083685 | Intermittent oral trimethoprim/sulfamethoxazole on two non-consecutive days per week is effective as Pneumocystis jiroveci pneumonia prophylaxis in pediatric patients receiving chemotherapy or hematopoietic stem cell transplantation |
| Q46080510 | Interstitial pneumonitis caused by Pneumocystis jirovecii pneumonia (PCP) during bortezomib treatment |
| Q44022125 | Intestinal perforation due to concomitant cytomegalovirus infection during treatment for Pneumocystis jirovecii pneumonia in a patient with rheumatoid arthritis |
| Q41698398 | Intrabronchial valves for treatment of alveolar-pleural fistula in a patient with Pneumocystis jirovecii pneumonia |
| Q65465380 | Intravenous Pentamidine for Pneumocystis Jirovecii Pneumonia |
| Q36137354 | Investigation of Pneumocystis jirovecii colonization in patients with chronic pulmonary diseases in the People's Republic of China |
| Q43984114 | Investigation of Pneumocystis jirovecii in Respiratory Samples of Immunocompromised Patients with PCR, IFA and Giemsa Staining Methods |
| Q44036448 | Investigation of Pneumocystis jirovecii in clinical specimens by different methods |
| Q41111567 | Investigation of Pneumocystis jirovecii pneumonia and colonization in iatrogenically immunosuppressed and immunocompetent patients |
| Q40342053 | Investigation of outbreaks of Pneumocystis jirovecii pneumonia in two Scottish renal units. |
| Q101561555 | Is Routine Prophylaxis Against Pneumocystis jirovecii Needed in Liver Transplantation? A Retrospective Single-Centre Experience and Current Prophylaxis Strategies in Spain |
| Q38073854 | Is caspofungin really an effective treatment for Pneumocystis jirovecii pneumonia in immunocompromised patients without human immunodeficiency virus infection? Experiences at a single center and a literature review. |
| Q44428609 | Is it safe to discontinue primary Pneumocystis jiroveci pneumonia prophylaxis in patients with virologically suppressed HIV infection and a CD4 cell count <200 cells/microL? |
| Q94481950 | Is real time PCR preferable to the direct immunofluorescence in the diagnosis of Pneumocystis jirovecii pneumonia in HIV-infected patients? |
| Q80481667 | Is there anything new in Pneumocystis jirovecii pneumonia? Changes in P. jirovecii pneumonia over the course of the AIDS epidemic |
| Q62487989 | Isolates of Pneumocystis jirovecii from Harare show high genotypic similarity to isolates from London at the superoxide dismutase locus |
| Q57749860 | It Is Time to Move:Pneumocystis Jirovecii, NotPneumocystis Carinii |
| Q57749971 | It's Pneumocystis jiroveci Not Pneumocystis carinii |
| Q27677147 | Kinetic and Structural Analysis for Potent Antifolate Inhibition of Pneumocystis jirovecii, Pneumocystis carinii, and Human Dihydrofolate Reductases and Their Active-Site Variants |
| Q92985959 | Lack of development of Pneumocystis jirovecii Pneumonia in a cohort of 103 Italian glioblastoma patients not receiving prophylaxis during post-surgical chemoradiotherapy |
| Q37706068 | Late Onset Combined Immunodeficiency Presenting with Recurrent Pneumocystis jiroveci Pneumonia |
| Q41810279 | Late presentation of Pneumocystis jiroveci pneumonia after cardiac transplantation |
| Q50315617 | Late presentation of Pneumocystis jirovecii pneumonia after renal transplant: A case report |
| Q88887041 | Late-onset Pneumocystis jirovecii pneumonia (PJP) in patients with ANCA-associated vasculitis |
| Q39265885 | Late-onset Pneumocystis jirovecii pneumonia in solid organ transplant recipients |
| Q38106512 | Late-onset Pneumocystis jirovecii pneumonia post-fludarabine, cyclophosphamide and rituximab: implications for prophylaxis |
| Q38168983 | Legionella pneumophila and Pneumocystis jirovecii coinfection in an infant treated with adrenocorticotropic hormone for infantile spasm: case report and literature review |
| Q92019831 | Leishmania donovani and Pneumocystis jirovecii (carinii) diagnosed on bronchoalveolar lavage cytology in a liver transplant recipient with Cytomegalovirus infection |
| Q38937278 | Lethal Pneumocystis jiroveci pneumonia 24 Years After Kidney Transplantation |
| Q99370729 | Letter: Invasive nocardiosis, disseminated varicella zoster reactivation and pneumocystis jiroveci pneumoniae associated with tofacitinib and concomitant systemic corticosteroid use in ulcerative colitis |
| Q40208314 | Life-Threatening Hypercalcemia During Prodrome of Pneumocystis jiroveci Pneumonia in an Immunocompetent Infant. |
| Q43647676 | Life-threatening Pneumocystis jiroveci pneumonia following treatment of severe Cushing's syndrome. |
| Q92135386 | Life-threatening hyperkalaemia due to trimethoprim in a patient treated for Pneumocystis jirovecii pneumonia |
| Q33719796 | Lifelong Prophylaxis With Trimethoprim-Sulfamethoxazole for Prevention of Outbreak of Pneumocystis jirovecii Pneumonia in Kidney Transplant Recipients |
| Q101558872 | Lifelong, Universal Pneumocystis jirovecii Pneumonia Prophylaxis: Patient uptake and adherence after kidney transplant |
| Q40597881 | Limited asymptomatic carriage of Pneumocystis jiroveci in human immunodeficiency virus-infected patients |
| Q43293130 | Linking Pneumocystis jiroveci sulfamethoxazole resistance to the alleles of the DHPS gene using functional complementation in Saccharomyces cerevisiae |
| Q100528965 | Long-lasting Cluster of Nosocomial Pneumonia with A Single Pneumocystis Jirovecii Genotype Involving Different Organ Allograft Recipients |
| Q91405760 | Long-read sequencing based clinical metagenomics for the detection and confirmation of Pneumocystis jirovecii directly from clinical specimens: A paradigm shift in mycological diagnostics |
| Q75309526 | Long-term colonization with Pneumocystis jirovecii in hospital staffs: a challenge to prevent nosocomial pneumocystosis |
| Q37272778 | Long-term serologic responses to the Pneumocystis jirovecii major surface glycoprotein in HIV-positive individuals with and without P. jirovecii infection. |
| Q113910713 | Low Dose Trimethoprim-Sulfamethoxazole for the Treatment of Pneumocystis Jirovecii Pneumonia |
| Q55519151 | Low Lymphocyte Proportion in Bronchoalveolar Lavage Fluid as a Risk Factor Associated with the Change from Trimethoprim/sulfamethoxazole used as First-Line Treatment for Pneumocystis jirovecii Pneumonia. |
| Q127195234 | Low Risk of Pneumocystis Jirovecii Pneumonia in Inflammatory Bowel Disease Patients Receiving Immunosuppressive Therapy: A Population-Based Cohort Study: 2016 ACG Fellows-In-Training Award (IBD Category) |
| Q40396288 | Low Risk of Pneumonia From Pneumocystis jirovecii Infection in Patients With Inflammatory Bowel Disease Receiving Immune Suppression |
| Q48149226 | Low Titer Pneumocystis jirovecii Infections: More than Just Colonization? |
| Q38964649 | Low genetic diversity of Pneumocystis jirovecii among Cuban population based on two-locus mitochondrial typing. |
| Q50784148 | Low incidence of Pneumocystis jirovecii pneumonia in an unprophylaxed liver transplant cohort. |
| Q38902083 | Low prevalence of DHFR and DHPS mutations in Pneumocystis jirovecii strains obtained from a German cohort |
| Q35841375 | Low prevalence of Pneumocystis jirovecii lung colonization in Ugandan HIV-infected patients hospitalized with non-Pneumocystis pneumonia |
| Q93260931 | Low risk of Pneumocystis jirovecii pneumonia and invasive aspergillosis in patients with Waldenström macroglobulinaemia on ibrutinib |
| Q92048547 | Low-Dose Cotrimoxazole Administered in Hematopoietic Stem Cell Transplant Recipients as Prophylaxis for Pneumocystis jirovecii Pneumonia Is Effective in Prevention of Infection due to Nocardia |
| Q94547610 | Low-Dose TMP-SMX in the Treatment of Pneumocystis jirovecii Pneumonia: A Systematic Review and Meta-analysis |
| Q83225278 | Low-dose trimethoprim-sulfamethoxazole for Pneumocystis jiroveci pneumonia prophylaxis after allogeneic hematopoietic SCT |
| Q100417466 | Lower Mortality Associated With Adjuvant Corticosteroid Therapy in Non-HIV-Infected Patients With Pneumocystis jirovecii Pneumonia: A Single-Institution Retrospective US Cohort Study |
| Q39438349 | Lower incidence of Pneumocystis jirovecii pneumonia among Africans in the Netherlands host or environmental factors? |
| Q36162399 | Lung co-infection by Pneumocystis jirovecii and Pseudomonas aeruginosa in AIDS: report of two cases |
| Q45930311 | Lung ultrasound can differentiate Pneumocystis jiroveci versus other etiologies among critically ill AIDS patients with pneumonia. |
| Q75309589 | Lymphocyte response in subjects with chronic pulmonary disease colonized by Pneumocystis jirovecii |
| Q58480108 | Lymphocyte surge as a marker for immunorestitution disease due to Pneumocystis jiroveci pneumonia in HIV-negative immunosuppressed hosts |
| Q52728260 | Lymphopenia is associated with late onset Pneumocystis jirovecii pneumonia in solid organ transplantation. |
| Q127520685 | MON-189 SAFETY AND EFFICACY OF PROPHYLAXIS FOR PNEUMOCYSTIS JIROVECII PNEUMONIA INVOLVING TRIMETHOPRIM-SULFAMETHOXAZOLE DOSE REDUCTION IN KIDNEY TRANSPLANTATION |
| Q35557252 | Management of Pneumocystis Jirovecii pneumonia in HIV infected patients: current options, challenges and future directions |
| Q40437254 | Management of Pneumocystis jiroveci pneumonia in children receiving chemotherapy |
| Q36288984 | Management of Pneumocystis jirovecii Pneumonia in Kidney Transplantation to Prevent Further Outbreak |
| Q47097269 | Mechanisms of Surface Antigenic Variation in the Human Pathogenic Fungus Pneumocystis jirovecii |
| Q98945448 | Metagenomic Next-Generation Sequencing in Diagnosis of a Case of Pneumocystis jirovecii Pneumonia in a Kidney Transplant Recipient and Literature Review |
| Q45596620 | Metagenomic analysis of bronchoalveolar lavage samples from patients with idiopathic interstitial pneumonia and its antagonic relation with Pneumocystis jirovecii colonization. |
| Q80766189 | Methaemoglobinaemia causing progressive dyspnoea and cyanosis during treatment of Pneumocystis jirovecii pneumonia |
| Q94606033 | Methemoglobinemia: a challenge while managing pneumocystis jirovecii pneumonia |
| Q50263345 | Microscopic diagnosis of Pneumocystis jirovecii pneumonia in bronchoalveolar lavage and oropharyngeal wash samples of immunocompromised patients with pneumonia |
| Q39459196 | Mixed Pulmonary Infection with Penicillium notatum and Pneumocystis jiroveci in a Patient with Acute Myeloid Leukemia |
| Q90440434 | Molecular Diagnosis of Pneumocystis jirovecii Pneumonia by Use of Oral Wash Samples in Immunocompromised Patients: Usefulness and Importance of the DNA Target |
| Q128987013 | Molecular Study of Pneumocystis jirovecii in Respiratory Samples of HIV Patients in Chile |
| Q47236186 | Molecular analysis based on mtLSU-rRNA and DHPS sequences of Pneumocystis jirovecii from immunocompromised and immunocompetent patients in Italy |
| Q44630376 | Molecular basis for atovaquone resistance in Pneumocystis jirovecii modeled in the cytochrome bc(1) complex of Saccharomyces cerevisiae |
| Q40256686 | Molecular detection of DHFR gene polymorphisms in Pneumocystis jirovecii isolates from Indian patients |
| Q33851360 | Molecular detection of Pneumocystis jirovecii using polymerase chain reaction in immunocompromised patients with pulmonary disorders in northeast of Iran |
| Q41674713 | Molecular detection of pneumocystis jirovecii in patients with respiratory tract infections |
| Q54324919 | Molecular diagnosis and detection of Pneumocystis jirovecii DHPS and DHFR genotypes in respiratory specimens from Colombian patients. |
| Q92075130 | Molecular diagnosis and genotyping of Pneumocystis jirovecii in bronchoalveolar lavage samples obtained from patients with pulmonary disorder |
| Q84002523 | Molecular diagnosis of Pneumocystis jiroveci pneumonia in immunocompromised patients |
| Q40214531 | Molecular diagnosis of Pneumocystis jirovecii in patients with malignancy: clinical significance of quantitative polymerase chain reaction |
| Q44526885 | Molecular epidemiology linking multihospital clusters of opportunistic Pneumocystis jirovecii pneumonia |
| Q42203880 | Molecular epidemiology of Pneumocystis jiroveci in human immunodeficiency virus-positive and -negative immunocompromised patients in The Netherlands |
| Q39631694 | Molecular evidence of Pneumocystis jirovecii reinfection in a haemato-oncology patient. |
| Q24652970 | Molecular evidence of nosocomial Pneumocystis jirovecii transmission among 16 patients after kidney transplantation |
| Q80063759 | Molecular typing of Pneumocystis jirovecii found in formalin-fixed paraffin-embedded lung tissue sections from sudden infant death victims |
| Q84938066 | Molecular typing of Pneumocystis jirovecii in a patient from French Guiana |
| Q44767924 | Mortality predictors of Pneumocystis jirovecii pneumonia in human immunodeficiency virus-infected patients at presentation: Experience in a tertiary care hospital of northern Taiwan |
| Q40456629 | Multi-skeletal Pneumocystis jiroveci (carinii) in an HIV-seropositive patient. |
| Q28542714 | Multicenter study of trimethoprim/sulfamethoxazole-related hepatotoxicity: incidence and associated factors among HIV-infected patients treated for Pneumocystis jirovecii pneumonia |
| Q35066605 | Multicenter, prospective clinical evaluation of respiratory samples from subjects at risk for Pneumocystis jirovecii infection by use of a commercial real-time PCR assay |
| Q38995757 | Multicentre study highlighting clinical relevance of new high-throughput methodologies in molecular epidemiology of Pneumocystis jirovecii pneumonia |
| Q75309576 | Multilocus genotyping of Pneumocystis jirovecii from adult HIV-infected patients with Pneumocystis pneumonia |
| Q38954176 | Multilocus genotyping of Pneumocystis jirovecii in immunocompromised patients: preliminary results |
| Q75309587 | Multilocus genotyping of Pneumocystis jirovecii in patients developing diverse forms of parasitism: implication for a wide human reservoir for the fungus |
| Q37713756 | Multilocus microsatellite genotyping array for investigation of genetic epidemiology of Pneumocystis jirovecii |
| Q42573454 | Multilocus sequence typing of Pneumocystis jirovecii from clinical samples: how many and which loci should be used? |
| Q49541092 | Multiple Lung Cysts Due to pneumocystis jirovecii Pneumonia |
| Q35036051 | Mutational analysis of Pneumocystis jirovecii dihydropteroate synthase and dihydrofolate reductase genes in HIV-infected patients in China |
| Q40450855 | Mutations in the Pneumocystis jirovecii DHPS gene confer cross-resistance to sulfa drugs. |
| Q38954187 | Mutations in the dihydropteroate synthase gene of Pneumocystis jiroveci isolates from Portuguese patients with Pneumocystis pneumonia. |
| Q37598743 | Mutations of Pneumocystis jirovecii dihydrofolate reductase associated with failure of prophylaxis. |
| Q127094611 | NECROTIZING CAVITARY LUNG MASS IN PATIENT WITH AIDS: A RARE MANIFESTATION OF PNEUMOCYSTIS JIROVECII PNEUMONIA |
| Q54205172 | Negative role of malnutrition in cell-mediated immune response: Pneumocystis jirovecii pneumonia (PCP) in a severely malnourished, HIV-negative patient with anorexia nervosa. |
| Q35561221 | New Short Tandem Repeat-Based Molecular Typing Method for Pneumocystis jirovecii Reveals Intrahospital Transmission between Patients from Different Wards |
| Q33511054 | Newly formed cystic lesions for the development of pneumomediastinum in Pneumocystis jirovecii pneumonia |
| Q43899085 | No occurrence of Pneumocystis jiroveci (carinii) pneumonia in 120 adults undergoing myeloablative unrelated cord blood transplantation. |
| Q36364216 | No recurrence of Pneumocystis jirovecii Pneumonia after solid organ transplantation regardless of secondary prophylaxis. |
| Q59354420 | Nodular granulomatous Pneumocystis jiroveci pneumonia consequent to delayed immune reconstitution inflammatory syndrome |
| Q43647727 | Non-human immunodeficiency virus Pneumocystis jiroveci pneumonia. |
| Q30859949 | Nonadherence to primary prophylaxis against Pneumocystis jirovecii pneumonia |
| Q51700500 | Noninvasive mechanical ventilation in patient with pneumocystis jirovecii pneumonia: case report. |
| Q37278530 | Nosocomial Pneumocystis jirovecii infections |
| Q43853029 | Nosocomial Pneumocystis jirovecii pneumonia: lessons from a cluster in kidney transplant recipients. |
| Q91112584 | Novel dihydropteroate synthase gene mutation in Pneumocystis jirovecii among HIV-infected patients in India: Putative association with drug resistance and mortality |
| Q81189068 | Occurrence of Pneumocystis jiroveci pneumonia after allogeneic stem cell transplantation: a 6-year retrospective study |
| Q48327169 | Opportunist Turns Allergen: Double Life of Pneumocystis jirovecii in Asthma |
| Q94472984 | Opportunistic coinfection with Pneumocystis jirovecii and Coccidioides immitis associated with idelalisib treatment in a patient with chronic lymphocytic leukaemia |
| Q24203996 | Optimal timing for discontinuation of Pneumocystis jiroveci pneumonia prophylaxis in adult patients on highly active antiretroviral therapy (HAART) for HIV infection |
| Q59392800 | Optimal timing for discontinuation of Pneumocystis jiroveci pneumonia prophylaxis in adult patients on highly active antiretroviral therapy (HAART) for HIV infection |
| Q43250359 | Oral atovaquone for the treatment of severe Pneumocystis jirovecii pneumonia in a patient with glucose-6-phosphate dehydrogenase deficiency |
| Q80889854 | Organizing pneumonia as a manifestation of Pneumocystis jiroveci immune reconstitution syndrome in HIV-positive patients: report of 2 cases |
| Q98944815 | Organizing pneumonia secondary to Pneumocystis jirovecii infection in a kidney transplant recipient: Case report and review of literature |
| Q122737999 | Outbreak of Pneumocystis Jirovecii Pneumonia in a British Renal Transplant Centre: Evidence for human to human transmission, or an environmental source of infection |
| Q84379727 | Outbreak of Pneumocystis jiroveci pneumonia in renal transplant recipients: P. jiroveci is contagious to the susceptible host |
| Q38761368 | Outbreak of Pneumocystis jirovecii Infection among Heart Transplant Recipients: Molecular Investigation and Management of an Inter-human Transmission |
| Q42206832 | Outbreak of Pneumocystis jirovecii pneumonia in renal transplant recipients on prophylaxis: our observation and experience |
| Q37305589 | Outbreak of pneumocystis pneumonia in renal and liver transplant patients caused by genotypically distinct strains of Pneumocystis jirovecii |
| Q91538854 | Outbreak-Causing Fungi: Pneumocystis jirovecii |
| Q91498075 | Outcome and prognostic factors of Pneumocystis jirovecii pneumonia in immunocompromised adults: a prospective observational study |
| Q43285299 | Outcome from treatment of Pneumocystis jirovecii pneumonia with co-trimoxazole |
| Q40294167 | Outcome of Pneumocystis jirovecii pneumonia diagnosed by polymerase chain reaction in patients without human immunodeficiency virus infection |
| Q35629437 | Outcomes and duration of Pneumocystis jiroveci pneumonia therapy in infants with severe combined immunodeficiency |
| Q33768267 | Outcomes and prognostic factors of non-HIV patients with pneumocystis jirovecii pneumonia and pulmonary CMV co-infection: A Retrospective Cohort Study |
| Q35162881 | Outcomes of Pneumocystis jiroveci pneumonia infections in pediatric heart transplant recipients |
| Q42314489 | Overcoming Hurdles to Development of a Vaccine against Pneumocystis jirovecii |
| Q127320388 | P14.128 Lack of development of Pneumocystis Jirovecii Pneumonia in a cohort of 103 Italian glioblastoma patients not receiving prophylaxis during post-surgical chemoradiotherapy |
| Q128103638 | PNEUMOCYSTIS JIROVECI PNEUMONIA IN A CHILD WITH HIV AND SEVERE MALNUTRITION: AN EXPERIENCE FROM RESOURCE-LIMITED SETTING |
| Q127095388 | PNEUMOCYSTIS JIROVECII PNEUMONIA AS A PRESENTATION OF IDIOPATHIC CD4 LYMPHOCYTOPENIA |
| Q127092721 | PNEUMOCYSTIS JIROVECII PRESENTING AS ASYMPTOMATIC CAVITARY LUNG LESION |
| Q34718247 | Pafuramidine for Pneumocystis jiroveci pneumonia in HIV-infected individuals |
| Q104467939 | Panniculitis in a Woman With Opportunistic Pulmonary Coinfection by Pneumocystis jirovecii and Cryptococcus neoformans: 18F-FDG PET/CT Revealing the Infection and Assessing Treatment Response |
| Q45261258 | Pathology quiz case 2. Pneumocystis carinii (also known as Pneumocystis jiroveci) infection of the right temporal bone |
| Q88984665 | Pentamidine for Prophylaxis against Pneumocystis jirovecii Pneumonia in Pediatric Oncology Patients Receiving Immunosuppressive Chemotherapy |
| Q26751428 | Pentamidine in Pneumocystis jirovecii prophylaxis in heart transplant recipients |
| Q36620917 | Performances of Four Real-Time PCR Assays for Diagnosis of Pneumocystis jirovecii Pneumonia. |
| Q54432895 | Plasma concentrations of atovaquone given to immunocompromised patients to prevent Pneumocystis jirovecii. |
| Q40369147 | Platypnea and orthodeoxia associated with Pneumocystis jiroveci and Cytomegalovirus pneumonia: a case report |
| Q42332537 | Platypnea-orthodeoxia syndrome in idiopathic pulmonary fibrosis with Pneumocystis jiroveci pneumonia |
| Q58795405 | Pneumocystis Jiroveci Pneumonia and Newly Diagnosed Human Immunodeficiency Virus (AIDS) in a 63-Year-Old Woman |
| Q127111604 | Pneumocystis Jirovecii Pneumonia (PCP) in Children with Cancer: A Retrospective Cohort Analysis from the Pediatric Health Information System (PHIS) Database, 2004-2009 |
| Q88248549 | Pneumocystis Jirovecii Pneumonia During Sirolimus Therapy for Kaposiform Hemangioendothelioma |
| Q127094684 | Pneumocystis Jirovecii Pneumonia In Recipients Of Autologous Hematopoietic Stem Cell Transplantation: A 10-Year Cohort Study |
| Q90415655 | Pneumocystis Jirovecii Pneumonia after Initiation of Tofacitinib Therapy in Rheumatoid Arthritis: Case-Based Review |
| Q96824244 | Pneumocystis Jirovecii Pneumonia and SARS-CoV-2 Co-Infection in newly diagnosed HIV-1 infection |
| Q86051300 | Pneumocystis Jirovecii Pneumonia in Japanese Patients with Rheumatoid Arthritis Treated with Tumor Necrosis Factor Inhibitors: A Pooled Analysis of 3 Agents |
| Q90154166 | Pneumocystis Jirovecii Pneumonia in Newly Diagnosed HIV Infection: A Challenging Case Report |
| Q40708317 | Pneumocystis Jirovecii Pneumonia in a Patient with Anti-N-Methyl-D-Aspartate Receptor Postherpetic Encephalitis. |
| Q40782096 | Pneumocystis Jirovecii Presenting as Nodular Pulmonary Opacities |
| Q96134186 | Pneumocystis Jirovecii detection and comparison of multiple diagnostic methods with quantitative real-time PCR in patients with respiratory symptoms |
| Q95933707 | Pneumocystis Jirovecii in Immunocompromised Patients with Rheumatic Diseases |
| Q128476196 | Pneumocystis Jirovecii: Quality Improvement of Prophylaxis in Hematopoietic Stem Cell Transplant Patients |
| Q53731156 | Pneumocystis carinii versus Pneumocystis jirovecii (jiroveci) Frenkel. |
| Q42734897 | Pneumocystis carinii vs. Pneumocystis jiroveci: another misnomer (response to Stringer et al.). |
| Q89447506 | Pneumocystis jiroveci |
| Q36789194 | Pneumocystis jiroveci (carinii) pneumonia after infliximab therapy: a review of 84 cases |
| Q81767452 | Pneumocystis jiroveci (carinii) pneumonia after initiation of infliximab and azathioprine therapy in a patient with Crohn's disease |
| Q82846369 | Pneumocystis jiroveci (carinii) pneumonia following a second infusion of infliximab in a patient with ulcerative colitis |
| Q80844359 | Pneumocystis jiroveci (carinii) pneumonia following initiation of infliximab and azathioprine therapy in a patient with Crohn's disease |
| Q43636895 | Pneumocystis jiroveci (carinii) pneumonia undergoing cavitation |
| Q45396644 | Pneumocystis jiroveci (formally carinii) pneumonia in older immunocompromised non-human immunodeficiency virus (non-HIV) patients: 2 cases and a literature review |
| Q80906330 | Pneumocystis jiroveci (formerly Pneumocystis carinii) |
| Q60466236 | Pneumocystis jiroveci Pneumonia Revealing De Novo Mutation Causing X-Linked Hyper-IgM Syndrome in an Infant Male. The First Case Reported From French Guiana |
| Q94922858 | Pneumocystis jiroveci Pneumonia in HIV-Positive and HIV-Negative Patients: A Single-Center Retrospective Study |
| Q36399801 | Pneumocystis jiroveci Pneumonia in an Atypical Host |
| Q42976797 | Pneumocystis jiroveci and cytomegalovirus pneumonia in patients with alcoholic hepatic cirrhosis |
| Q42805368 | Pneumocystis jiroveci dihydropteroate synthase gene mutations among colonized individuals and Pneumocystis pneumonia patients from Spain. |
| Q82299711 | Pneumocystis jiroveci dihydropteroate synthase gene mutations at codon 171 but not at codons 55 or 57 detected in Germany |
| Q35124449 | Pneumocystis jiroveci dihydropteroate synthase polymorphisms confer resistance to sulfadoxine and sulfanilamide in Saccharomyces cerevisiae |
| Q47966742 | Pneumocystis jiroveci genotypes in the Spanish population. |
| Q83172676 | Pneumocystis jiroveci in HIV/AIDS patients: detection by FTA filter paper together with PCR in noninvasive induced sputum specimens |
| Q39225094 | Pneumocystis jiroveci in Portuguese immunocompromised patients: association of specific ITS genotypes with treatment failure, bad clinical outcome and childhood |
| Q91940674 | Pneumocystis jiroveci in solid organ transplantation: Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice |
| Q40340347 | Pneumocystis jiroveci infection associated with organizing pneumonia in a kidney transplant patient |
| Q41168939 | Pneumocystis jiroveci infection in patients with and without HIV: A comparison |
| Q80184435 | Pneumocystis jiroveci infection in patients with hyper-immunoglobulin E syndrome |
| Q34747032 | Pneumocystis jiroveci internal transcribed spacer types in patients colonized by the fungus and in patients with pneumocystosis from the same French geographic region |
| Q53893950 | Pneumocystis jiroveci isolates with dihydropteroate synthase mutations in patients with chronic bronchitis. |
| Q28258329 | Pneumocystis jiroveci n. sp. from man: morphology, physiology, and immunology in relation to pathology |
| Q34186416 | Pneumocystis jiroveci outbreak in a renal transplant center: Lessons learnt |
| Q80497353 | Pneumocystis jiroveci pneumonia (PCP) in HIV-1-negative patients: a retrospective study 2002-2004 |
| Q40974744 | Pneumocystis jiroveci pneumonia (PCP) in patients receiving neoadjuvant and adjuvant anthracycline-based chemotherapy for breast cancer: incidence and risk factors |
| Q30408727 | Pneumocystis jiroveci pneumonia (PCP) misdiagnosed as pandemic influenza H1N1 in a renal transplant patient |
| Q47937549 | Pneumocystis jiroveci pneumonia (PJP) in non-HIV immunocompromised individuals |
| Q46900425 | Pneumocystis jiroveci pneumonia (PcP) in patients with rheumatic diseases: case report and review |
| Q54445274 | Pneumocystis jiroveci pneumonia and GATA2 deficiency: Expanding the spectrum of the disease. |
| Q41837588 | Pneumocystis jiroveci pneumonia and colonization in patients with advanced lung cancer |
| Q46724615 | Pneumocystis jiroveci pneumonia and other pulmonary infections in TB smear-negative HIV-positive patients with atypical chest X-ray in Ethiopia |
| Q43144371 | Pneumocystis jiroveci pneumonia and pneumomediastinum in an anti-TNFalpha naive patient with ulcerative colitis |
| Q46926821 | Pneumocystis jiroveci pneumonia as a complication of glucocorticoid therapy for interstitial pneumonia |
| Q47927494 | Pneumocystis jiroveci pneumonia as an atypical presentation of X-linked agammaglobulinemia |
| Q36452691 | Pneumocystis jiroveci pneumonia associated with low-dose methotrexate treatment for rheumatoid arthritis: report of two cases and review of the literature |
| Q43196834 | Pneumocystis jiroveci pneumonia detected by FDG-PET. |
| Q46257177 | Pneumocystis jiroveci pneumonia during prolonged corticosteroid therapy in an immunocompetent infant |
| Q37768109 | Pneumocystis jiroveci pneumonia following rituximab treatment in Wegener's granulomatosis |
| Q79085320 | Pneumocystis jiroveci pneumonia in AIDS patients: reactivation, reinfection or both? |
| Q95499447 | Pneumocystis jiroveci pneumonia in Taiwan from 2014 to 2017: Clinical manifestations and outcomes between pediatric and adult patients |
| Q54230949 | Pneumocystis jiroveci pneumonia in a patient taking Benepali for rheumatoid arthritis. |
| Q46601999 | Pneumocystis jiroveci pneumonia in a patient with Wegener's granulomatosis treated efficiently with caspofungin |
| Q53542319 | Pneumocystis jiroveci pneumonia in a patient with rheumatoid arthritis as a complication of treatment with infliximab, anti-tumor necrosis factor alpha neutralizing antibody. |
| Q36013688 | Pneumocystis jiroveci pneumonia in adult patients with AIDS: treatment strategies and emerging challenges to antimicrobial therapy |
| Q43270786 | Pneumocystis jiroveci pneumonia in an immunocompetent female patient |
| Q53156010 | Pneumocystis jiroveci pneumonia in an immunocompetent patient. |
| Q37846515 | Pneumocystis jiroveci pneumonia in an infant with severe folate deficiency |
| Q34970288 | Pneumocystis jiroveci pneumonia in giant cell arteritis: A case series |
| Q54287856 | Pneumocystis jiroveci pneumonia in immunocompromised patients: delayed diagnosis and poor outcomes in non-HIV-infected individuals. |
| Q38101453 | Pneumocystis jiroveci pneumonia in inflammatory bowel disease: when should prophylaxis be considered? |
| Q59336177 | Pneumocystis jiroveci pneumonia in kidney and simultaneous pancreas kidney transplant recipients in the present era of routine post-transplant prophylaxis: risk factors and outcomes |
| Q42212297 | Pneumocystis jiroveci pneumonia in patients receiving dasatinib treatment |
| Q38786977 | Pneumocystis jiroveci pneumonia in patients treated with systemic immunosuppressive agents for dermatologic conditions: a systematic review with recommendations for prophylaxis |
| Q39839185 | Pneumocystis jiroveci pneumonia in patients with AIDS in the inner city: a persistent and deadly opportunistic infection |
| Q45330600 | Pneumocystis jiroveci pneumonia in patients with inflammatory bowel disease: a survey of prophylaxis patterns among gastroenterology providers |
| Q37128026 | Pneumocystis jiroveci pneumonia in patients with non-Hodgkin's lymphoma after Rituximab-containing regimen: two cases of report and literature review |
| Q53438572 | Pneumocystis jiroveci pneumonia in patients with non-Hodgkin's lymphoma receiving chemotherapy containing rituximab. |
| Q37402664 | Pneumocystis jiroveci pneumonia in patients with rheumatoid arthritis treated with infliximab: a retrospective review and case-control study of 21 patients. |
| Q40298025 | Pneumocystis jiroveci pneumonia in patients with systemic lupus erythematosus after rituximab therapy |
| Q85154448 | Pneumocystis jiroveci pneumonia in relation to CD4+ lymphocyte count in patients with B-cell non-Hodgkin lymphoma treated with chemotherapy |
| Q84671158 | Pneumocystis jiroveci pneumonia in renal transplantation: time to review our practice? |
| Q38992555 | Pneumocystis jiroveci pneumonia in rheumatic disease: a 20-year single-centre experience. |
| Q84795025 | Pneumocystis jiroveci pneumonia prophylaxis during maintenance therapy influences methotrexate/6-mercaptopurine dosing but not event-free survival for childhood acute lymphoblastic leukemia |
| Q59465588 | Pneumocystis jiroveci pneumonia prophylaxis is not required with a CD4+ T-cell count < 200 cells/??l when viral replication is suppressed |
| Q87241016 | Pneumocystis jiroveci pneumonia with recurrent pneumothorax requiring pleurodesis in inflammatory bowel disease |
| Q46710890 | Pneumocystis jiroveci pneumonia. |
| Q41696346 | Pneumocystis jiroveci pneumonia: comparative study of cases in HIV-infected patients and immunocompromised non-HIV-infected patients |
| Q43885604 | Pneumocystis jiroveci pneumonia: first documented case in Libreville, Gabon |
| Q28267338 | Pneumocystis jiroveci pneumonia: high-resolution CT findings in patients with and without HIV infection |
| Q40602395 | Pneumocystis jiroveci pneumonitis complicating ruxolitinib therapy |
| Q35512260 | Pneumocystis jiroveci prophylaxis in patients undergoing Bendamustine treatment: the need for a standardized protocol |
| Q36974864 | Pneumocystis jiroveci thyroiditis: report of 15 cases in the literature |
| Q36189505 | Pneumocystis jiroveci. Applied molecular microbiology, epidemiology and diagnosis |
| Q58868588 | Pneumocystis jirovecii |
| Q58868589 | Pneumocystis jirovecii |
| Q101559158 | Pneumocystis jirovecii |
| Q42249389 | Pneumocystis jirovecii (Pj) quantitative PCR to differentiate Pj pneumonia from Pj colonization in immunocompromised patients. |
| Q40025167 | Pneumocystis jirovecii Colonization in Non-HIV-Infected Patients Based on Nested-PCR Detection in Bronchoalveolar Lavage Samples |
| Q89965351 | Pneumocystis jirovecii Diversity in Réunion, an Overseas French Island in Indian Ocean |
| Q88094513 | Pneumocystis jirovecii Exhalation in the Course of Pneumocystis Pneumonia Treatment |
| Q60369702 | Pneumocystis jirovecii Genotypes in European Patients with Chronic Obstructive Pulmonary Diseases |
| Q127117834 | Pneumocystis jirovecii Infection of the Liver Presenting With Acutely Elevated Liver Functions Tests |
| Q37695587 | Pneumocystis jirovecii Pneumonia |
| Q92862884 | Pneumocystis jirovecii Pneumonia and Human Immunodeficiency Virus Co-Infection in Western Iran |
| Q89533562 | Pneumocystis jirovecii Pneumonia and Other Infections in Idiopathic Inflammatory Myositis |
| Q39225077 | Pneumocystis jirovecii Pneumonia in Africa: Impact and Implications of Highly Sensitive Diagnostic Technologies |
| Q104071878 | Pneumocystis jirovecii Pneumonia in Children with Hematological Malignancies: Diagnosis and Approaches to Management |
| Q129674303 | Pneumocystis jirovecii Pneumonia in HIV-Negative, Non-transplant Patients: Epidemiology, Clinical Manifestations, Diagnosis, Treatment, and Prevention |
| Q30385635 | Pneumocystis jirovecii Pneumonia in Human Immunodeficiency Virus Infection. |
| Q90648708 | Pneumocystis jirovecii Pneumonia in Patients With Metastatic Prostate Cancer on Corticosteroids for Malignant Spinal Cord Compression: Two Case Reports and a Guideline Review |
| Q90148934 | Pneumocystis jirovecii Pneumonia in Patients with Nephrotic Syndrome: Application of Lymphocyte Subset Analysis in Predicting Clinical Outcomes |
| Q40100993 | Pneumocystis jirovecii Pneumonia in Pediatric Inflammatory Bowel Disease: A Case Report and Literature Review |
| Q26781920 | Pneumocystis jirovecii Pneumonia in Rheumatoid Arthritis Patients: Risks and Prophylaxis Recommendations |
| Q104062179 | Pneumocystis jirovecii Pneumonia in Solid-Organ Transplant Recipients: A National Center Experience |
| Q98240749 | Pneumocystis jirovecii Pneumonia in a HIV-Infected Patient with a CD4 Count Greater Than 400 Cells/μL and Atovaquone Prophylaxis |
| Q92591348 | Pneumocystis jirovecii Pneumonia in a Non-small Cell Lung Cancer Patient on Chemoradiotherapy: A Case Report |
| Q91992219 | Pneumocystis jirovecii Pneumonia in a Patient with Breast Cancer Receiving Neoadjuvant Dose-dense Chemotherapy |
| Q41281466 | Pneumocystis jirovecii Pneumonia in a Patient with Interstitial Lung Disease |
| Q34278716 | Pneumocystis jirovecii Pneumonia in a Patient with Rheumatoid Arthritis Treated with Abatacept |
| Q40424187 | Pneumocystis jirovecii Pneumonia in a Treatment-Naive Patient With Chronic Lymphocytic Leukemia |
| Q91114208 | Pneumocystis jirovecii Pneumonia in an Infant: The Tip of the Iceberg |
| Q38848880 | Pneumocystis jirovecii Pneumonia in the Non-HIV-Infected Population |
| Q90779839 | Pneumocystis jirovecii Pneumonia-Associated Acute Respiratory Distress Syndrome Complicated by Pneumomediastinum and Pneumopericardium in a Non-Human Immunodeficiency Virus-Infected Patient |
| Q128938295 | Pneumocystis jirovecii Pneumonia: Current Advances in Laboratory Diagnosis |
| Q127235013 | Pneumocystis jirovecii Pneumonia: Epidemiology, Clinical Manifestation and Diagnosis |
| Q33798273 | Pneumocystis jirovecii Rtt109, a novel drug target for Pneumocystis pneumonia in immunosuppressed humans |
| Q46241377 | Pneumocystis jirovecii airborne transmission between critically ill patients and health care workers |
| Q38688718 | Pneumocystis jirovecii and Cystic Fibrosis in Brittany, France |
| Q60369440 | Pneumocystis jirovecii and Pneumocystosis |
| Q91825970 | Pneumocystis jirovecii and Toxoplasmosis prophylaxis strategies among pediatric organ transplantation recipients: A US National Survey |
| Q82411018 | Pneumocystis jirovecii and cystic fibrosis |
| Q38418192 | Pneumocystis jirovecii and cystic fibrosis in France |
| Q39776593 | Pneumocystis jirovecii and microbiological findings in children with severe pneumonia in Nairobi, Kenya |
| Q96122096 | Pneumocystis jirovecii and microsporidia: An unusual coinfection in HIV patients? |
| Q38995285 | Pneumocystis jirovecii can be productively cultured in differentiated CuFi-8 airway cells |
| Q39225102 | Pneumocystis jirovecii carriage in Portuguese immunocompetent patients: preliminary results |
| Q39398078 | Pneumocystis jirovecii colonisation in HIV-positive and HIV-negative subjects in Cameroon |
| Q43551628 | Pneumocystis jirovecii colonisation in patients with interstitial lung disease. |
| Q39012798 | Pneumocystis jirovecii colonization among renal transplant recipients |
| Q51013373 | Pneumocystis jirovecii colonization and infection among non HIV-infected patients. |
| Q90525356 | Pneumocystis jirovecii colonization and its association with pulmonary diseases: a multicenter study based on a modified loop-mediated isothermal amplification assay |
| Q39417008 | Pneumocystis jirovecii colonization in Chronic Obstructive Pulmonary Disease (COPD). |
| Q37890370 | Pneumocystis jirovecii colonization in chronic pulmonary disease |
| Q83383828 | Pneumocystis jirovecii colonization in patients treated with infliximab |
| Q56978010 | Pneumocystis jirovecii colonization in patients with systemic autoimmune diseases: prevalence, risk factors of colonization and outcome |
| Q33933207 | Pneumocystis jirovecii colonization is associated with enhanced Th1 inflammatory gene expression in lungs of humans with chronic obstructive pulmonary disease |
| Q33777831 | Pneumocystis jirovecii detection in asymptomatic patients: what does its natural history tell us? |
| Q44736817 | Pneumocystis jirovecii dihydrofolate reductase polymorphisms associated with failure of prophylaxis |
| Q84759535 | Pneumocystis jirovecii dihydropteroate synthase (DHPS) genotypes in non-HIV-immunocompromised patients: a tertiary care reference health centre study |
| Q45409202 | Pneumocystis jirovecii dihydropteroate synthase gene mutations and human immunodeficiency virus-associated Pneumocystis pneumonia. |
| Q34445099 | Pneumocystis jirovecii dihydropteroate synthase gene mutations in a group of HIV-negative immunocompromised patients with Pneumocystis pneumonia |
| Q53905951 | Pneumocystis jirovecii dihydropteroate synthase genotypes in French patients with pneumocystosis: a 1998-2001 prospective study. |
| Q35880166 | Pneumocystis jirovecii dihydropteroate synthase genotypes in immunocompetent infants and immunosuppressed adults, Amiens, France |
| Q36570827 | Pneumocystis jirovecii genotype associated with increased death rate of HIV-infected patients with pneumonia. |
| Q83035810 | Pneumocystis jirovecii genotypes and granulomatous pneumocystosis |
| Q45912774 | Pneumocystis jirovecii genotypes involved in pneumocystis pneumonia outbreaks among renal transplant recipients. |
| Q47175653 | Pneumocystis jirovecii genotyping: experience in a tertiary-care hospital in Northern Italy |
| Q50780797 | Pneumocystis jirovecii haplotypes at the internal transcribed spacers of the rRNA operon in French HIV-negative patients with diverse clinical presentations of Pneumocystis infections. |
| Q91673324 | Pneumocystis jirovecii immunostain versus Gomori/Grocott methenamine silver stain of bronchoalveolar lavage in cell blocks: an institutional experience |
| Q101053831 | Pneumocystis jirovecii in Patients With Cystic Fibrosis: A Review |
| Q90932383 | Pneumocystis jirovecii in Spanish Patients With Heart Failure |
| Q85200497 | Pneumocystis jirovecii in a bronchoalveolar lavage specimen on ThinPrep® cytology |
| Q91940907 | Pneumocystis jirovecii in a patient on dose-dense chemotherapy for early breast cancer |
| Q28238490 | Pneumocystis jirovecii in general population |
| Q56398054 | Pneumocystis jirovecii in pleural infection: a nucleic acid amplification study |
| Q129749377 | Pneumocystis jirovecii in solid organ transplant recipients: updates in epidemiology, diagnosis, treatment, and prevention |
| Q41173430 | Pneumocystis jirovecii in the air surrounding patients with Pneumocystis pulmonary colonization |
| Q43058977 | Pneumocystis jirovecii infection |
| Q41722661 | Pneumocystis jirovecii infection and the associated dihydropteroate synthase (DHPS) and dihydrofolate reductase (DHFR) mutations in HIV-positive individuals from Pune, India |
| Q89067355 | Pneumocystis jirovecii infection in patients with acute interstitial pneumonia |
| Q93190906 | Pneumocystis jirovecii infection of bilateral adrenal glands in an immunocompetent adult: a case report |
| Q36434896 | Pneumocystis jirovecii infection: an emerging threat to patients with rheumatoid arthritis |
| Q37781065 | Pneumocystis jirovecii multilocus gene sequencing: findings and implications |
| Q38995782 | Pneumocystis jirovecii multilocus genotyping in pooled DNA samples: a new approach for clinical and epidemiological studies |
| Q38108723 | Pneumocystis jirovecii multilocus genotyping profiles in Northern Ireland |
| Q38995803 | Pneumocystis jirovecii multilocus genotyping profiles in patients from Portugal and Spain |
| Q57788671 | Pneumocystis jirovecii pneumonia (PCP) PCR-negative conversion predicts prognosis of HIV-negative patients with PCP and acute respiratory failure |
| Q93199921 | Pneumocystis jirovecii pneumonia (PJP) prophylaxis patterns among patients with rheumatic diseases receiving high-risk immunosuppressant drugs |
| Q84056126 | Pneumocystis jirovecii pneumonia 13 years post renal transplant following a recurrent cytomegalovirus infection |
| Q102370810 | Pneumocystis jirovecii pneumonia PCR test on upper respiratory tract swab |
| Q43605225 | Pneumocystis jirovecii pneumonia after rituximab therapy for antibody-mediated rejection in a renal transplant recipient |
| Q45369021 | Pneumocystis jirovecii pneumonia and alveolar hemorrhage in a pregnant woman with human T cell lymphotropic virus type-1 infection |
| Q91861909 | Pneumocystis jirovecii pneumonia and institutional prophylaxis practices in CLL patients treated with BTK inhibitors |
| Q84717792 | Pneumocystis jirovecii pneumonia as a complication of bendamustine in a patient receiving bendamustine plus rituximab for marginal zone lymphoma |
| Q64247663 | Pneumocystis jirovecii pneumonia as an initial manifestation of hyper-IgM syndrome in an infant: A case report |
| Q64947214 | Pneumocystis jirovecii pneumonia as first manifestation of late relapse angioimmunoblastic T-cell lymphoma. |
| Q37987077 | Pneumocystis jirovecii pneumonia associated with etanercept treatment in patients with rheumatoid arthritis: a retrospective review of 15 cases and analysis of risk factors |
| Q42225847 | Pneumocystis jirovecii pneumonia associated with gemcitabine chemotherapy: experience at an Australian center and recommendations for targeted prophylaxis |
| Q92461407 | Pneumocystis jirovecii pneumonia at chest High-resolution Computed Tomography (HRCT) in non-HIV immunocompromised patients: Spectrum of findings and mimickers |
| Q52143518 | Pneumocystis jirovecii pneumonia complicating the progress of a patient with glioblastoma multiforme receiving temozolomide. |
| Q89206943 | Pneumocystis jirovecii pneumonia developed in a patient with rheumatoid arthritis after 14 weeks of iguratimod add-on to treatment with methotrexate and etanercept |
| Q34436156 | Pneumocystis jirovecii pneumonia following everolimus treatment of metastatic breast cancer |
| Q89466486 | Pneumocystis jirovecii pneumonia in AIDS and non-AIDS immunocompromised patients - an update |
| Q79926185 | Pneumocystis jirovecii pneumonia in African miners at autopsy |
| Q54561806 | Pneumocystis jirovecii pneumonia in B-cell lymphoma patients treated with the rituximab-CHOEP-14 regimen. |
| Q99706822 | Pneumocystis jirovecii pneumonia in Diffuse Large B-Cell Lymphoma Treated with R-CHOP |
| Q86520791 | Pneumocystis jirovecii pneumonia in HIV-1-infected patients in the late-HAART era in developed countries |
| Q42231929 | Pneumocystis jirovecii pneumonia in HIV-negative patients: a prospective study with focus on immunosuppressive drugs and markers of immune impairment |
| Q55545384 | Pneumocystis jirovecii pneumonia in HIV-uninfected, rituximab treated non-Hodgkin lymphoma patients. |
| Q30431684 | Pneumocystis jirovecii pneumonia in Latin America. A public health problem? |
| Q45133130 | Pneumocystis jirovecii pneumonia in Spanish HIV-infected patients in the combined antiretroviral therapy era: prevalence of dihydropteroate synthase mutations and prognostic factors of mortality |
| Q51753899 | Pneumocystis jirovecii pneumonia in a baby with hyper-IgE syndrome. |
| Q90696122 | Pneumocystis jirovecii pneumonia in a human immunodeficiency virus-infected patient with G6PD deficiency-successful treatment with anidulafungin |
| Q89418720 | Pneumocystis jirovecii pneumonia in a patient with pustular psoriasis with an IL-36RN deficiency treated with infliximab: Case report and review of the literature |
| Q90952350 | Pneumocystis jirovecii pneumonia in an HIV-infected patient mimicking acute eosinophilic pneumonia: a case report with a review of the literature |
| Q130166984 | Pneumocystis jirovecii pneumonia in an immunocompromised patient on methotrexate: A case report |
| Q91618666 | Pneumocystis jirovecii pneumonia in children. A retrospective study in a single center over three decades |
| Q37926917 | Pneumocystis jirovecii pneumonia in developing countries |
| Q54367805 | Pneumocystis jirovecii pneumonia in everolimus-treated renal cell carcinoma. |
| Q37957313 | Pneumocystis jirovecii pneumonia in kidney transplantation |
| Q38270976 | Pneumocystis jirovecii pneumonia in liver transplant recipients: a systematic review |
| Q38221817 | Pneumocystis jirovecii pneumonia in mycophenolate mofetil-treated patients with connective tissue disease: analysis of 17 cases |
| Q34020193 | Pneumocystis jirovecii pneumonia in non-HIV infected patients: a study of 41 cases |
| Q38032135 | Pneumocystis jirovecii pneumonia in non-HIV-infected patients in the era of novel immunosuppressive therapies |
| Q41397468 | Pneumocystis jirovecii pneumonia in non-HIV-infected patients in the era of novel immunosuppressive therapies |
| Q37944081 | Pneumocystis jirovecii pneumonia in non-HIV-infected patients: new risks and diagnostic tools |
| Q38245616 | Pneumocystis jirovecii pneumonia in patients receiving tumor-necrosis-factor-inhibitor therapy: implications for chemoprophylaxis |
| Q97541364 | Pneumocystis jirovecii pneumonia in patients treated for systemic autoimmune disorders: a retrospective analysis of patient characteristics and outcome |
| Q49340035 | Pneumocystis jirovecii pneumonia in patients treated with rituximab for systemic diseases: Report of 11 cases and review of the literature |
| Q48286433 | Pneumocystis jirovecii pneumonia in patients with acute myeloid leukaemia. |
| Q39495702 | Pneumocystis jirovecii pneumonia in patients with and without human immunodeficiency virus infection. |
| Q38364778 | Pneumocystis jirovecii pneumonia in patients with autoimmune disease on high-dose glucocorticoid |
| Q50100529 | Pneumocystis jirovecii pneumonia in patients with autoimmune diseases |
| Q42201539 | Pneumocystis jirovecii pneumonia in patients with end-stage renal disease: a comparison with the general population |
| Q34259891 | Pneumocystis jirovecii pneumonia in patients with or without AIDS, France |
| Q38909875 | Pneumocystis jirovecii pneumonia in pediatric patients: an analysis of 15 confirmed consecutive cases during 14 years |
| Q43204905 | Pneumocystis jirovecii pneumonia in renal transplant recipients occurring after discontinuation of prophylaxis: a case–control study |
| Q42260686 | Pneumocystis jirovecii pneumonia in renal transplant recipients: a national center experience |
| Q91193720 | Pneumocystis jirovecii pneumonia in solid organ transplant recipients: a descriptive analysis for the Swiss Transplant Cohort |
| Q39214252 | Pneumocystis jirovecii pneumonia in systemic autoimmune rheumatic disease: A case-control study |
| Q44476541 | Pneumocystis jirovecii pneumonia in systemic lupus erythematosus from southern Taiwan |
| Q34924811 | Pneumocystis jirovecii pneumonia in tropical and low and middle income countries: a systematic review and meta-regression |
| Q87056543 | Pneumocystis jirovecii pneumonia in two patients with systemic lupus erythematosus after rituximab therapy |
| Q47150407 | Pneumocystis jirovecii pneumonia induced by low-dose methotrexate in a patient with chronic urticaria. |
| Q64121224 | Pneumocystis jirovecii pneumonia infection in pemphigus patients treated with rituximab: an observational nationwide epidemiological study in Taiwan |
| Q50992836 | Pneumocystis jirovecii pneumonia is rare in renal transplant recipients receiving only one month of prophylaxis. |
| Q130132754 | Pneumocystis jirovecii pneumonia presenting with severe, refractory hypercalcaemia in an immunosuppressed renal transplant patient: Review of the literature and novel biochemical insights |
| Q38038351 | Pneumocystis jirovecii pneumonia prophylaxis during temozolomide treatment for high-grade gliomas. |
| Q101236938 | Pneumocystis jirovecii pneumonia prophylaxis in a 42-year-old woman on immunosuppressive therapy |
| Q58561044 | Pneumocystis jirovecii pneumonia prophylaxis in allogeneic hematopoietic cell transplant recipients: can we always follow the guidelines? |
| Q92414494 | Pneumocystis jirovecii pneumonia prophylaxis in hematopoietic stem cell transplantation, is it acceptable to wait for the engraftment for restarting it? |
| Q92250820 | Pneumocystis jirovecii pneumonia prophylaxis in immunocompromised patients with systemic autoimmune diseases |
| Q51704257 | Pneumocystis jirovecii pneumonia under everolimus in two patients with metastatic pancreatic neuroendocrine tumors. |
| Q45145271 | Pneumocystis jirovecii pneumonia with an atypical granulomatous response after kidney transplantation |
| Q92917511 | Pneumocystis jirovecii pneumonia: A potential complication of sirolimus therapy |
| Q38953280 | Pneumocystis jirovecii pneumonia: still a concern in patients with haematological malignancies and stem cell transplant recipients-authors' response |
| Q54534916 | Pneumocystis jirovecii pneumonia: still a concern in patients with haematological malignancies and stem cell transplant recipients. |
| Q92976360 | Pneumocystis jirovecii pneumonitis: cause of acute hypercalcaemia in chronic haemodialysis patient |
| Q84532165 | Pneumocystis jirovecii prophylaxis discontinuation based upon total lymphocyte count in HIV-infected adults treated with antiretroviral therapy |
| Q100462412 | Pneumocystis jirovecii prophylaxis in neurosurgery |
| Q92446463 | Pneumocystis jirovecii prophylaxis in patients treated for high-grade gliomas: a survey among neuro-oncologists |
| Q83251795 | Pneumocystis jirovecii testing by real-time polymerase chain reaction and direct examination among immunocompetent and immunosuppressed patient groups and correlation to disease specificity |
| Q37009424 | Pneumocystis jirovecii transmission from immunocompetent carriers to infant |
| Q26797509 | Pneumocystis jirovecii--from a commensal to pathogen: clinical and diagnostic review |
| Q38746714 | Pneumocystis jirovecii-induced chronic interstitial lung disease in Waldenström's macroglobulinemia |
| Q61446284 | Pneumocystis jirovecii-related spontaneous pneumothorax, pneumomediastinum and subcutaneous emphysema in a liver transplant recipient: a case report |
| Q104479586 | Pneumocystis jirovecii: the Changing Landscape for Prophylaxis |
| Q37790390 | Pneumocystis jiroveciiinfection: Cell wall (1→3)-β-D-glucan biology and diagnostic utility |
| Q41733873 | Pneumocystis pneumonia (PCP) and Pneumocystis jirovecii carriage in renal transplantation patients: a single-centre experience. |
| Q84025757 | Pneumocystis pneumonia: immunosuppression, Pneumocystis jirovecii...and the third man |
| Q42230410 | Pneumocystis polymerase chain reaction and blood (1→3)-β-D-glucan assays to predict survival with suspected Pneumocystis jirovecii pneumonia |
| Q92482926 | Pneumomediastinum Associated with HIV-positive Pneumocystis jirovecii Pneumonia |
| Q84794670 | Pneumomediastinum in a patient with pneumocystis jirovecii pneumonia |
| Q36684110 | Pneumomediastinum, pneumorrhachis, and subcutaneous emphysema in Pneumocystis jiroveci pneumonia in AIDS |
| Q37327136 | Pneumonia involving Mycobacterium tuberculosis and Pneumocystis jiroveci in HIV-seronegative patients |
| Q92756029 | Point-Counterpoint: Should Serum β-d-Glucan Testing Be Used for the Diagnosis of Pneumocystis jirovecii Pneumonia? |
| Q53692070 | Point-of-care lung ultrasound for diagnosis of Pneumocystis jirovecii pneumonia: notes from the field. |
| Q36906353 | Polymerase chain reaction detection of Pneumocystis jiroveci: evaluation of 9 assays. |
| Q54432218 | Polymerase chain reaction positivity of Pneumocystis jirovecii during primary lung cancer treatment. |
| Q84278263 | Polymerase chain reaction-based detection of Pneumocystis jirovecii in bronchoalveolar lavage fluid for the diagnosis of pneumocystis pneumonia |
| Q83063119 | Polymorphisms in Pneumocystis jirovecii strains in Spanish children with cystic fibrosis |
| Q91711645 | Polymorphisms involving the Pneumocystis jirovecii-related genes in AIDS patients in eastern China |
| Q40800021 | Pondering Mating: Pneumocystis jirovecii, the Human Lung Pathogen, Selfs without Mating Type Switching, in Contrast to Its Close Relative Schizosaccharomyces pombe |
| Q38995789 | Population structure of Pneumocystis jirovecii isolated from immunodeficiency virus-positive patients |
| Q55129706 | Positive Pneumocystis jirovecii Sputum PCR Results with Negative Bronchoscopic PCR Results in Suspected Pneumocystis Pneumonia. |
| Q43180357 | Possible nosocomial transmission of Pneumocystis jirovecii |
| Q30423995 | Possible pandemic HIN1 influenza complicated by Pneumocystis jirovecii pneumonia in an HIV-infected patient |
| Q36744771 | Post-diagnostic kinetics of the (1 → 3)-β-D-glucan assay in invasive aspergillosis, invasive candidiasis and Pneumocystis jirovecii pneumonia |
| Q38112260 | Post-transplant Pneumocystis jirovecii pneumonia--a re-emerged public health problem? |
| Q37366760 | Potential consequences of essential drug shortages in Canada: Brain abscess due to Nocardia farcinica associated with dapsone prophylaxis for Pneumocystis jirovecii pneumonia |
| Q64276146 | Potential role of CT-textural features for differentiation between viral interstitial pneumonias, pneumocystis jirovecii pneumonia and diffuse alveolar hemorrhage in early stages of disease: a proof of principle |
| Q42381994 | Pregnancy and asymptomatic carriage of Pneumocystis jiroveci |
| Q81377918 | Prematurity and protracted mechanical ventilation as risk factors for Pneumocystis jiroveci infection in HIV-negative neonates in an intensive care unit |
| Q39388847 | Prescription of Pneumocystis Jiroveci Pneumonia Prophylaxis in HIV-Infected Patients |
| Q127134491 | Prevalence and Risk Factors Associated With Pneumocystis jiroveci Pneumonia After Liver Transplantation |
| Q37546684 | Prevalence and genotype distribution of Pneumocystis jirovecii in Cuban infants and toddlers with whooping cough |
| Q58614726 | Prevalence and genotyping of Pneumocystis jirovecii in renal transplant recipients-preliminary report |
| Q54567271 | Prevalence of DHPS polymorphisms associated with sulfa resistance in South African Pneumocystis jirovecii strains. |
| Q90933983 | Prevalence of Opportunistic Pathogens Pneumocystis jiroveci and Tubercle Bacilli in HIV-Infected Patients with Respiratory Infections in Yaounde, Cameroon |
| Q64660648 | Prevalence of Pneumocystis Jirovecii and of Cytomegalovirus in Bronchial Wash Fluid of Patients Undergoing Bronchoscopy |
| Q40076877 | Prevalence of Pneumocystis jirovecii among immunocompromised patients in hospitals of Tehran city, Iran |
| Q40614814 | Prevalence of Pneumocystis jirovecii colonization in autopsy cases in Turkey |
| Q42210085 | Prevalence of Pneumocystis jirovecii pneumonia (2010-2013): the first Croatian report |
| Q46819801 | Prevalence of colonisation and genotypic characterisation of Pneumocystis jirovecii among cystic fibrosis patients in Spain |
| Q37611881 | Prevalence of colonization and mitochondrial large subunit rRNA mutation of Pneumocystis jiroveci among Iranian children |
| Q46486326 | Prevalence of dihydropteroate synthase mutants in HIV-infected South African children with Pneumocystis jiroveci pneumonia |
| Q43946973 | Prevalences of Pneumocystis jiroveci, Mycobacterium tuberculosis and Streptococcus pneumoniae infection in children with severe pneumonia, in a tertiary referral hospital in northern Tanzania |
| Q59780363 | Prevalencia de mutaciones en el gen de la dihidropteroato sintetasa de Pneumocystis jiroveci en pacientes con sida en España |
| Q46822536 | Preventive effect of sulfamethoxasole-trimethoprim on Pneumocystis jiroveci pneumonia in patients with interstitial pneumonia |
| Q40361300 | Primary cytomegalovirus infection with accompanying Pneumocystis jiroveci pneumonia in a patient with large-vessel vasculitis |
| Q85016620 | Primary prophylaxis for Pneumocystis jirovecii pneumonia in patients with connective tissue diseases |
| Q38081793 | Primary prophylaxis of bacterial infections and Pneumocystis jirovecii pneumonia in patients with hematological malignancies and solid tumors : guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncol |
| Q81148238 | Probable mother to infant transmission of Pneumocystis jiroveci from an HIV-infected woman to her HIV-uninfected infant |
| Q54567234 | Problems of developing molecular diagnostic tests for opportunistic pathogens: the example of Pneumocystis jirovecii. |
| Q84784711 | Procalcitonin serum concentration during Pneumocystis jiroveci colonization or Pseudomonas aeruginosa infection/colonization in lung transplant recipients |
| Q36148851 | Prognostic factors for severe Pneumocystis jiroveci pneumonia of non-HIV patients in intensive care unit: a bicentric retrospective study |
| Q42225047 | Prognostic factors of Pneumocystis jirovecii pneumonia in patients without HIV infection |
| Q64117776 | Prognostic significance of crazy paving ground grass opacities in non-HIV Pneumocystis jirovecii pneumonia: an observational cohort study |
| Q37727733 | Prognostic value of C-reactive protein in HIV-infected patients with Pneumocystis jirovecii pneumonia. |
| Q92843787 | Programmed death ligand 1 is overexpressed by neutrophils in the blood of immunocompromised human immunodeficiency virus-negative patients with Pneumocystis jirovecii pneumonia |
| Q79211879 | Progression of Pneumocystis jiroveci pneumonia in patients receiving echinocandin therapy |
| Q37234955 | Prophylactic antibiotic usage for Pneumocystis jirovecii pneumonia in patients with systemic lupus erythematosus on cyclophosphamide: a survey of US rheumatologists and the review of literature |
| Q104744521 | Prophylaxie pour la pneumonie à Pneumocystis jirovecii chez une femme de 42 ans suivant un traitement immunosuppresseur |
| Q86081743 | Prophylaxis against Pneumocystis jirovecii pneumonia in patients with adult T-cell lymphoma/leukemia receiving anti-CC chemokine receptor 4 monoclonal antibody |
| Q35613669 | Prophylaxis and Treatment of Pneumocystis jiroveci Pneumonia in Lymphoma Patients Subjected to Rituximab-Contained Therapy: A Systemic Review and Meta-Analysis |
| Q56957441 | Prophylaxis and treatment of Pneumocystis Jirovecii pneumonia after solid organ transplantation |
| Q38378391 | Prophylaxis for Pneumocystis jiroveci pneumonia: is it a necessity in pulmonary patients on high-dose, chronic corticosteroid therapy without AIDS? |
| Q36414080 | Prospective multicenter study of Pneumocystis jirovecii colonization among cystic fibrosis patients in France. |
| Q43358363 | Pulmonary alveolar proteinosis secondary to Pneumocystis jiroveci infection in an infant with common variable immunodeficiency |
| Q92819155 | Pulmonary co-infection with Pneumocystis jirovecii and Histoplasma capsulatum in AIDS patients is not a rare event |
| Q39404140 | Pulmonary co-infections by Pneumocystis jirovecii and Aspergillus fumigatus in non-HIV patients: A report of two cases and literature review |
| Q129659985 | Pulmonary co-infections by Pneumocystis jirovecii and Herpesviridae: a seven-year retrospective study |
| Q38097444 | Pulmonary coinfection by Pneumocystis jiroveci and Cryptococcus neoformans |
| Q91968743 | Pulmonary coinfection by Pneumocystis jirovecii and Cryptococcus species in a patient with undiagnosed advanced HIV |
| Q44132781 | Pulmonary embolism in patients with acquired immunodeficiency syndrome presenting with clinical picture of Pneumocystis jiroveci pneumonia: report of two cases |
| Q40426922 | Pulmonary infiltrates and fever in a HIV infected patient after Pneumocystis jirovecii pneumonia |
| Q98620742 | Pulmonary tuberculosis and pneumocystis jirovecii concurrent pneumonia in HIV infected patients at a resource limited setting in Eastern India: A case series |
| Q40446959 | Purification and characterization of human-derived Pneumocystis jirovecii dihydrofolate reductase expressed in Sf21 insect cells and in Escherichia coli. |
| Q84465083 | Quantification and spread of Pneumocystis jirovecii in the surrounding air of patients with Pneumocystis pneumonia |
| Q92326769 | Quantification of Pneumocystis jirovecii: Cross-Platform Comparison of One qPCR Assay with Leading Platforms and Six Master Mixes |
| Q41722330 | Quantification of the effect of chemotherapy and steroids on risk of Pneumocystis jiroveci among hospitalized patients with adult T-cell leukaemia. |
| Q73492961 | Quantitation of anti-Pneumocystis jiroveci antibodies in healthy persons and immunocompromised patients |
| Q46378111 | Quantitative TaqMan PCR for detection of Pneumocystis jiroveci |
| Q61833835 | Quantitative real-time PCR and the (1 → 3)-β-d-glucan assay for differentiation between Pneumocystis jirovecii pneumonia and colonization |
| Q97523946 | Radiographic features in investigated for Pneumocystis jirovecii pneumonia: a nested case-control study |
| Q129846333 | Radiological features of AIDS-related pneumocystis jiroveci infection |
| Q53316142 | Radiological features of Pneumocystis jirovecii Pneumonia in immunocompromised patients with and without AIDS. |
| Q51512795 | Radiological presentation of Pneumocystis jiroveci pneumonia mimicking bacterial pneumonia. |
| Q83219054 | Radiology corner. Answer to last month's radiology case (28): Pneumocystis jiroveci pneumonia |
| Q54733143 | Real time quantitative PCR assay for Pneumocystis jirovecii detection. |
| Q46594118 | Real-time PCR assay for the diagnosis of Pneumocystis jirovecii pneumonia. |
| Q54406595 | Real-time PCR assay-based strategy for differentiation between active Pneumocystis jirovecii pneumonia and colonization in immunocompromised patients. |
| Q57912850 | Reasons for Lack of Appropriate Receipt of Primary Pneumocystis jiroveci Pneumonia Prophylaxis among HIV-Infected Persons Receiving Treatment in the United States: 1994-2003 |
| Q35685361 | Recapitulation in Saccharomyces cerevisiae of cytochrome b mutations conferring resistance to atovaquone in Pneumocystis jiroveci |
| Q38093248 | Recent advances in the diagnosis of Pneumocystis jirovecii pneumonia in HIV-infected adults |
| Q40054529 | Refractory acute respiratory failure due to Pneumocystis jiroveci (PCP) and Cytomegalovirus (CMV) pneumonitis: A case report and review of literature |
| Q34177387 | Relationship of Pneumocystis jiroveci humoral immunity to prevention of colonization and chronic obstructive pulmonary disease in a primate model of HIV infection |
| Q80850820 | Remission of nephrotic membranous glomerulonephritis after high-dose trimethoprim-sulfamethoxazole treatment for pneumocystis jiroveci pneumonia |
| Q55288481 | Reply to Liu et al., "Inability To Culture Pneumocystis jirovecii". |
| Q59563739 | Reply to Nevez et al., "The Fascinating Echinocandin-Treated Mouse Model of Pneumocystis murina To Understand Pneumocystis jirovecii" |
| Q28279919 | Responsibility in naming pathogens: the case of Pneumocystis jirovecii, the causal agent of pneumocystis pneumonia |
| Q33579470 | Restriction fragment length polymorphism typing demonstrates substantial diversity among Pneumocystis jirovecii isolates |
| Q58416015 | Retrospective review of Pneumocystis jirovecii pneumonia in a French intensive care unit (1994–2000) |
| Q37405150 | Retrospective review of Pneumocystis jirovecii pneumonia over two decades |
| Q57610469 | Reversible Cystic Lesions ofPneumocystis jiroveciiPneumonia |
| Q129941447 | Rising Prevalence of Pneumocystis jirovecii Pneumonia Amongst the Non-HIV Immunosuppressed |
| Q38003754 | Rising incidence of Pneumocystis jirovecii pneumonia suggests iatrogenic exposure of immune-compromised patients may be becoming a significant problem |
| Q40417600 | Risk Evaluation and Outcome of Pneumocystis jirovecii Pneumonia in Kidney Transplant Patients. |
| Q92178119 | Risk Factors for Mortality in Pneumocystis jirovecii Pneumonia in Patients with Inflammatory Bowel Disease |
| Q88386095 | Risk Factors for Pneumocystis jirovecii Pneumonia in Patients With Rheumatoid Arthritis and a Prophylactic Indication of Trimethoprim/Sulfamethoxazole |
| Q33711158 | Risk Factors for the Mortality of Pneumocystis jirovecii Pneumonia in Non-HIV Patients Who Required Mechanical Ventilation: A Retrospective Case Series Study |
| Q36211354 | Risk factors analysis for Pneumocystis jiroveci pneumonia (PCP) in patients with haematological malignancies and pneumonia |
| Q61796216 | Risk factors and clinical characteristics of Pneumocystis jirovecii pneumonia in lung cancer |
| Q96166173 | Risk factors and prevention of Pneumocystis jirovecii pneumonia in patients with autoimmune and inflammatory diseases |
| Q98957081 | Risk factors associated with Pneumocystis jirovecii pneumonia in juvenile myositis in North America |
| Q82430801 | Risk factors for Pneumocystis jiroveci pneumonia (PcP) in renal transplant recipients |
| Q43621713 | Risk factors for Pneumocystis jiroveci pneumonia in glomerulonephritis patients receiving immunosuppressants |
| Q33685858 | Risk factors for Pneumocystis jirovecii pneumonia (PJP) in kidney transplantation recipients. |
| Q51026115 | Risk factors for Pneumocystis jirovecii pneumonia in kidney transplant recipients and appraisal of strategies for selective use of chemoprophylaxis. |
| Q43460343 | Risk factors for Pneumocystis jirovecii pneumonia in patients with lymphoproliferative disorders |
| Q91367008 | Risk of Death from Pneumocystis jirovecii after Curative-intent Radiotherapy for Lung Cancer |
| Q44992663 | Risk of Pneumocystis jiroveci pneumonia in patients long after renal transplantation |
| Q44278805 | Risk of Pneumocystis jirovecii pneumonia in patients with rheumatoid arthritis treated with inhibitors of tumour necrosis factor α: results from the British Society for Rheumatology Biologics Register for Rheumatoid Arthritis. |
| Q88335606 | Risk of Pneumonia Caused by Pneumocystis jiroveci in Inflammatory Bowel Disease: The Role of Concomitant Pulmonary Comorbidities |
| Q80497366 | Role of CD8 lymphocytes and neutrophilic alveolitis in Pneumocystis jiroveci pneumonia |
| Q84218498 | Role of PCR for diagnosing Pneumocystis jirovecii pneumonia in HIV-infected individuals in a tertiary care hospital in India |
| Q58694093 | Role of Pneumocystis jirovecii in patients with different pulmonary underlying condition using a nested-PCR |
| Q91639412 | Role of Pneumocystis jirovecii infection in chronic obstructive pulmonary disease progression in an immunosuppressed rat Pneumocystis pneumonia model |
| Q54425696 | Role of cytology and polymerase chain reaction based detection of Pneumocystis jirovecii infection in bronchoalveolar lavage fluid. |
| Q57063536 | Round opacity as a presentation of pneumocystis jirovecii pneumonia in an HIV-infected patient |
| Q40680315 | Safety and Effectiveness of Intravenous Pentamidine for Prophylaxis of Pneumocystis jirovecii Pneumonia in Pediatric Hematology/Oncology Patients. |
| Q64070515 | Safety and efficacy of prophylaxis for Pneumocystis jirovecii pneumonia involving trimethoprim-sulfamethoxazole dose reduction in kidney transplantation |
| Q93153740 | Safety of Trimethoprim-Sulfamethoxazole for Pneumocystis Jirovecii Pneumonia Prophylaxis in Patients Taking Methotrexate |
| Q57586379 | Seasonal variation in mortality of Pneumocystis jirovecii pneumonia in HIV-infected patients |
| Q46427486 | Seasonal variation of Pneumocystis jirovecii infection: analysis of underlying climatic factors |
| Q37116747 | Second-line salvage treatment of AIDS-associated Pneumocystis jirovecii pneumonia: a case series and systematic review |
| Q80067423 | Sensitive detection of Pneumocystis jirovecii DNA in gastric wash using nested polymerase chain reaction |
| Q54603284 | Sensitivity and specificity of nested and real-time PCR for the detection of Pneumocystis jiroveci in clinical specimens. |
| Q41354593 | Seroepidemiological study of Pneumocystis jirovecii infection in healthy infants in Chile using recombinant fragments of the P. jirovecii major surface glycoprotein |
| Q45731212 | Serologic responses to epitopes of the major surface glycoprotein of Pneumocystis jiroveci differ in human immunodeficiency virus-infected and uninfected persons. |
| Q35148566 | Serologic responses to pneumocystis proteins in HIV patients with and without Pneumocystis jirovecii pneumonia |
| Q34531964 | Serologic responses to recombinant Pneumocystis jirovecii major surface glycoprotein among Ugandan patients with respiratory symptoms |
| Q38797520 | Serological diagnosis of pneumocystosis: production of a synthetic recombinant antigen for immunodetection of Pneumocystis jirovecii |
| Q39512228 | Serum (1 → 3) β-D-glucan assay for discrimination between Pneumocystis jirovecii pneumonia and colonization |
| Q84622274 | Serum (1 → 3)-β-D-glucan measurement as an early indicator of Pneumocystis jirovecii pneumonia and evaluation of its prognostic value |
| Q97517417 | Serum (1,3)-Beta-D-Glucan has suboptimal performance for the diagnosis of Pneumocystis jirovecii pneumonia in cancer patients and correlates poorly with respiratory burden as measured by quantitative PCR |
| Q37451700 | Serum (1-3)-beta-D-glucan as a tool for diagnosis of Pneumocystis jirovecii pneumonia in patients with human immunodeficiency virus infection or hematological malignancy. |
| Q35066665 | Serum (1->3)-beta-D-glucan levels in primary infection and pulmonary colonization with Pneumocystis jirovecii |
| Q42929833 | Serum (1->3)-{beta}-D-Glucan assay for the diagnosis of Pneumocystis jiroveci pneumonia |
| Q59319860 | Serum (1→3) β‐D‐Glucan as a Noninvasive Adjunct Marker for the Diagnosis and Follow‐Up ofPneumocystis jiroveciPneumonia in Patients with HIV Infection |
| Q92321202 | Serum Soluble Interleukin-2 Receptor Is a Biomarker for Pneumocystis jirovecii Pneumonia among Patients with Rheumatoid Arthritis under Methotrexate Therapy |
| Q33769075 | Serum antibody levels to the Pneumocystis jirovecii major surface glycoprotein in the diagnosis of P. jirovecii pneumonia in HIV+ patients |
| Q33433277 | Serum markers in interstitial pneumonia with and without Pneumocystis jirovecii colonization: a prospective study |
| Q92131612 | Serum-based diagnosis of Pneumocystis pneumonia by detection of Pneumocystis jirovecii DNA and 1,3-β-D-glucan in HIV-infected patients: a retrospective case control study |
| Q33635195 | Severe Pneumocystis jirovecii pneumonia in an idiopathic CD4+ lymphocytopenia patient: case report and review of the literature |
| Q92786591 | Severe hypercalcemia preceding a diagnosis of Pneumocystis jirovecii pneumonia in a liver transplant recipient |
| Q41502821 | Severe pneumocystis jiroveci pneumonia in a patient on temozolomide therapy: A case report and review of literature |
| Q38479902 | Severe pneumonia caused by combined infection with Pneumocystis jiroveci, parainfluenza virus type 3, cytomegalovirus, and Aspergillus fumigatus in a patient with Stevens-Johnson syndrome/toxic epidermal necrolysis |
| Q46130038 | Severity and outcome of HIV-associated Pneumocystis pneumonia containing Pneumocystis jirovecii dihydropteroate synthase gene mutations |
| Q39550643 | Short Communication: Diagnosis of Pneumocystis jirovecii Pneumonia by Detection of DNA in Blood and Oropharyngeal Wash, Compared with Sputum |
| Q38113507 | Should Pneumocystis jiroveci prophylaxis be recommended with Rituximab treatment in ANCA-associated vasculitis? |
| Q44792472 | Should patients with malignancy receive chemoprophylaxis against Pneumocystis jirovecii pneumonia? |
| Q40998588 | Should prophylaxis for Pneumocystis jirovecii pneumonia be considered in patients with a CD4+ count higher than 200 cells/μl? |
| Q38447845 | Similar genotypes of Pneumocystis jirovecii in different forms of Pneumocystis infection |
| Q35140229 | Single nodular opacity of granulomatous pneumocystis jirovecii pneumonia in an asymptomatic lymphoma patient |
| Q51784234 | Single-center outbreak of Pneumocystis jirovecii pneumonia in heart transplant recipients. |
| Q91700446 | Site-Directed Mutagenesis of the 1,3-β-Glucan Synthase Catalytic Subunit of Pneumocystis jirovecii and Susceptibility Assays Suggest Its Sensitivity to Caspofungin |
| Q51720462 | Site-directed mutagenesis of the Saccharomyces cerevisiae dihydropteroate synthase FOL1 gene to study Pneumocystis jirovecii mutations in the orthologue gene FAS. |
| Q38039516 | Small-intestine pneumocystis jiroveci pseudotumor as an acquired immunodeficiency syndrome-presenting illness: report of a case and review of the literature |
| Q85849712 | Specific detection of Pneumocystis jirovecii in clinical samples by flow cytometry |
| Q42941547 | Spelling Pneumocystis jirovecii |
| Q41709324 | Spontaneous Pneumomediastinum, Pneumopericardium, and Pneumothorax with Respiratory Failure in a Patient with AIDS and Pneumocystis jirovecii Pneumonia |
| Q85835731 | Spontaneous remission of Pneumocystis jiroveci pneumonia in 2 non-AIDS immunocompromised patients |
| Q41785340 | Spontaneous resolution of Pneumocystis jirovecii pneumonia on high-resolution computed tomography in a patient with renal cell carcinoma |
| Q45235605 | Sterol composition of Pneumocystis jirovecii with blocked 14alpha-demethylase activity. |
| Q115667522 | Strongyloides stercoralis hyperinfection syndrome mimicking pseudomembranous enteritis, complicated by Escherichia coli bacteremia and Pneumocystis jirovecii pneumonia in a patient after immunosuppressive therapy: a case report |
| Q46642161 | Study of DHPS and DHFR genes of Pneumocystis jirovecii in Thai HIV-infected patients. |
| Q46107264 | Study of dihydropteroate synthase (DHPS) gene mutations among isolates of Pneumocystis jiroveci. |
| Q127926278 | Su1848 – Clinical Characteristics and Risk Factors for Pneumocystis Jirovecii Pneumonia in Patients with Inflammatory Bowel Disease |
| Q89882058 | Successful Extracorporeal Membrane Oxygenation Treatment in an Acquired Immune Deficiency Syndrome (AIDS) Patient with Acute Respiratory Distress Syndrome (ARDS) Complicating Pneumocystis jirovecii Pneumonia: A Challenging Case |
| Q58700627 | Successful long-term treatment of persistent pulmonary air leak in pneumocystis jirovecii pneumonia by unidirectional endobronchial valves |
| Q82151043 | Successful treatment with echinocandin in an HIV-infected individual failing first-line therapy for Pneumocystis jirovecii pneumonia |
| Q35880711 | Sulfa use, dihydropteroate synthase mutations, and Pneumocystis jirovecii pneumonia |
| Q53747576 | Survival after Pneumocystis jirovecii pneumonia requiring ventilation: A case report. |
| Q38782105 | Systematic review of outbreaks of Pneumocystis jirovecii pneumonia: evidence that P. jirovecii is a transmissible organism and the implications for healthcare infection control |
| Q80499495 | Systemic inflammation in patients with chronic obstructive pulmonary disease who are colonized with Pneumocystis jiroveci |
| Q100940203 | Targeted prophylaxis to prevent late-onset Pneumocystis jirovecii pneumonia in kidney transplantation. Are we there yet? |
| Q90094220 | Tension Pneumothorax Following Pneumocystis jirovecii Pneumonia |
| Q43967803 | Test performance of beta-glucan for Pneumocystis jirovecii pneumonia put in a clinical context |
| Q34273820 | Test performance of blood beta-glucan for Pneumocystis jirovecii pneumonia in patients with AIDS and respiratory symptoms |
| Q64951721 | The Fascinating Echinocandin-Treated Mouse Model of Pneumocystis murina To Understand Pneumocystis jirovecii. |
| Q91405745 | The Fungal PCR Initiative's evaluation of in-house and commercial Pneumocystis jirovecii qPCR assays: Toward a standard for a diagnostics assay |
| Q52657661 | The Impact of Absolute CD4 Count and Percentage Discordance on Pneumocystis Jirovecii Pneumonia Prophylaxis in HIV-Infected Patients. |
| Q91428924 | The Infectious Danger of Corticosteroids: A Fatal Case of Pneumocystis Jirovecii Pneumonia in a Non-HIV Patient Following Corticosteroid Use with Prophylaxis |
| Q50225539 | The Pneumocystis jirovecii colonization in bronchoalveolar lavage (BAL) and bronchial washing and the comparison of methods which are used in diagnosis |
| Q35104974 | The Prevalence of Pneumocystis jiroveci in Bronchoalveolar Lavage Specimens of Lung Transplant Recipients Examined by the Nested PCR. |
| Q104583642 | The Risk Factor Analysis and Treatment Experience in Pneumocystis Jirovecii Pneumonia After Kidney Transplantation |
| Q50032239 | The comparison of microscopy and real time polymerase chain reaction methods for the diagnosis of Pneumocystis Jirovecii pneumonia: evaluation of clinical parameters |
| Q45053722 | The development of a typing method for an uncultivable microorganism: the example of Pneumocystis jirovecii |
| Q35353152 | The effect of AIDS Clinical Trials Group Protocol 5164 on the time from Pneumocystis jirovecii pneumonia diagnosis to antiretroviral initiation in routine clinical practice: a case study of diffusion, dissemination, and implementation |
| Q34587043 | The impact of concomitant pulmonary infection on immune dysregulation in Pneumocystis jirovecii pneumonia |
| Q93026473 | The impact of cytomegalovirus infection on clinical severity and outcomes in kidney transplant recipients with Pneumocystis jirovecii pneumonia |
| Q35935057 | The impact of trimethoprim-sulfamethoxazole as Pneumocystis jiroveci pneumonia prophylaxis on the occurrence of asymptomatic bacteriuria and urinary tract infections among renal allograft recipients: a retrospective before-after study |
| Q44607577 | The importance of pro-inflammatory and anti-inflammatory cytokines in Pneumocystis jirovecii pneumonia |
| Q82411504 | The incidence of Pneumocystis jirovecii pneumonia is not higher in patients receiving dose-dense therapy with rituximab, cyclophosphamide, non-pegylated liposomal doxorubicin, vincristine, and prednisolone and adequate Pneumocystis jirovecii pneumon |
| Q36772325 | The incidence, mortality and timing of Pneumocystis jiroveci pneumonia after hematopoietic cell transplantation: a CIBMTR analysis |
| Q58089819 | The presence of Pneumocystis jirovecii DNA in plasma is associated with a higher mortality rate in patients with AIDS-associated Pneumocystis pneumonia |
| Q101407328 | The presence of Pneumocystis jirovecii in critically ill patients with COVID-19 |
| Q36577482 | The prevalence of Pneumocystis jirovecii among patients with different chronic pulmonary disorders in Ahvaz, Iran |
| Q39062899 | The role of CD4 cell count as discriminatory measure to guide chemoprophylaxis against Pneumocystis jirovecii pneumonia in human immunodeficiency virus-negative immunocompromised patients: A systematic review |
| Q24809668 | The unmasking of Pneumocystis jiroveci pneumonia during reversal of immunosuppression: case reports and literature review |
| Q38244198 | The use of ECMO in HIV/AIDS with Pneumocystis jirovecii Pneumonia: a case report and review of the literature |
| Q95937796 | The use of ECMO in acute respiratory failure caused by Pneumocystis jirovecii pneumonia after renal transplant: A case report |
| Q98506265 | The value of Pneumocystis jirovecii pneumonia prophylaxis in the era of personalized medicine |
| Q43284126 | Therapeutic failure in a renal transplant patient with Pneumocystis jiroveci pneumonia: a case report |
| Q93374087 | Therapy and Management of Pneumocystis jirovecii Infection |
| Q46898582 | Three cases of Pneumocystis jirovecii pneumonia (PCP) during first-line treatment with rituximab in combination with CHOP-14 for aggressive B-cell non-Hodgkin's lymphoma |
| Q79218107 | Thrombotic thrombocytopenic purpura as the initial presentation of Pneumocystis jiroveci pneumonia in an immunocompetent patient |
| Q89768226 | Tolerability of Aerosolized Versus Intravenous Pentamidine for Pneumocystis jirovecii Pneumonia Prophylaxis in Immunosuppressed Pediatric, Adolescent, and Young Adult Patients |
| Q41032776 | Tolerability of low-dose sulfamethoxazole/trimethoprim for Pneumocystis jirovecii pneumonia prophylaxis in kidney transplant recipients |
| Q50762422 | Toxicity and efficacy of daily dapsone as Pneumocystis jiroveci prophylaxis after hematopoietic stem cell transplantation: a case-control study. |
| Q40092648 | Treatment of Pneumocystis jirovecii pneumonia in HIV-infected patients: a review. |
| Q58061947 | Trends in Hospitalizations for AIDS-Associated Pneumocystis jirovecii Pneumonia in the United States (1986 to 2005) |
| Q35998150 | Trends in hospitalizations for Pneumocystis jiroveci pneumonia among patients with rheumatoid arthritis in the US: 1996-2007 |
| Q37263849 | Trimethoprim resistance of dihydrofolate reductase variants from clinical isolates of Pneumocystis jirovecii |
| Q44929842 | Trimethoprim-sulfamethoxazole exacerbates posthypoxic action myoclonus in a patient with suspicion of Pneumocystis jiroveci infection |
| Q46021027 | Trimetrexate and folinic acid: a valuable salvage option for Pneumocystis jirovecii pneumonia. |
| Q34151495 | Twice weekly Pneumocystis jiroveci pneumonia prophylaxis with trimethoprim-sulfamethoxazole in pediatric patients with acute lymphoblastic leukemia |
| Q104287881 | Twice weekly prophylaxis with trimethoprim/sulfamethoxazole for Pneumocystis jirovecii pneumonia in pediatric oncology patients |
| Q127729305 | Two Cases of Autoimmune Hepatitis Presenting with Pneumocystis jiroveci Pneumonia |
| Q42788268 | Two cases of Pneumocystis jiroveci pneumonia with non-Hodgkin's lymphoma after CHOP-based chemotherapy containing rituximab |
| Q42788630 | Two cases of fatal Pneumocystis jirovecii pneumonia as a complication of tacrolimus therapy in ulcerative colitis--a need for prophylaxis |
| Q91855355 | Two pediatric cases of Pneumocystis jirovecii pneumonia diagnosed by polymerase chain reaction of gastric lavage |
| Q40731214 | Typing of Pneumocystis jirovecii by multilocus sequencing: evidence of outbreak? |
| Q44452308 | Typing of Pneumocystis jirovecii isolates from Iranian immunosuppressed patients based on the Internal Transcribed Spacer (ITS) region of the rRNA gene. |
| Q48259901 | UK survey of Pneumocystis jirovecii pneumonia (PJP) prophylaxis use in paediatric oncology patients. |
| Q39649365 | Underlying renal insufficiency: the pivotal risk factor for Pneumocystis jirovecii pneumonia in immunosuppressed patients with non-transplant glomerular disease |
| Q88669812 | Unexpected Pneumocystis jirovecii pneumonia in patients with untreated chronic lymphocytic leukemia |
| Q42412860 | Unmasking Granulomatous Pneumocystis jirovecii Pneumonia with Nodular Opacity in an HIV-Infected Patient after Initiation of Antiretroviral Therapy. |
| Q81634080 | Unusual case of Pneumocystis jiroveci pneumonia during primary HIV infection |
| Q39363146 | Unusual coexistence of opportunistic lung infections in a human immunodeficiency virus positive patient suffering from persistent Pneumocystis jirovecii pneumonia: a case report |
| Q44266930 | Unusual presentation of bilateral bullous Pneumocystis jiroveci pneumonia complicated with pneumothorax |
| Q84374726 | Unusual presentation of serum markers for suspected Pneumocystis jiroveci pneumonia in a patient with diffuse large B-cell lymphoma |
| Q38196066 | Update on pulmonary Pneumocystis jirovecii infection in non-HIV patients |
| Q54227805 | Use of Induced sputum to determine the prevalence of Pneumocystis jirovecii in immunocompromised children with pneumonia. |
| Q35837803 | Use of Oropharyngeal Washes to Diagnose and Genotype Pneumocystis jirovecii |
| Q79609913 | Use of a serum (1-->3)-beta-D-glucan assay for diagnosis and follow-up of Pneumocystis jiroveci pneumonia |
| Q81424804 | Use of a serum beta-glucan assay for diagnosis of HIV-related Pneumocystis jiroveci pneumonia in patients with negative microscopic examination results |
| Q39452309 | Use of calcofluor-blue brightener for the diagnosis of Pneumocystis jirovecii pneumonia in bronchial-alveolar lavage fluids: A single-center prospective study |
| Q82732820 | Use of different primer directed sequence amplification by polymerase chain reaction for identification of Pneumocystis jirovecii in clinical samples |
| Q97558295 | Use of trimethoprim-sulfamethoxazole in a patient with G6PD deficiency for treating Pneumocystis jirovecii pneumonia without haemolysis: Case report and literature review |
| Q64906672 | Use of veno-venous extracorporeal life support in a patient with cytomegalovirus and Pneumocystis jiroveci related respiratory failure due to thymoma associated immunodeficiency: a case report. |
| Q40213626 | Usefulness of (1→3)β-D glucan in early diagnosing Pneumocystis jirovecii pneumonia: a case report |
| Q34554751 | Usefulness of 1,3 Beta-D-Glucan Detection in non-HIV Immunocompromised Mechanical Ventilated Critically Ill Patients with ARDS and Suspected Pneumocystis jirovecii Pneumonia |
| Q36064777 | Usefulness of Bronchoscopic Probe-Based Confocal Laser Endomicroscopy in the Diagnosis of Pneumocystis jirovecii Pneumonia |
| Q54567283 | Usefulness of oropharyngeal washings for identifying Pneumocystis jirovecii carriers. |
| Q40175494 | Utility of adding Pneumocystis jirovecii DNA detection in nasopharyngeal aspirates in immunocompromised adult patients with febrile pneumonia. |
| Q34573990 | Utility of reflex Gomori methenamine silver staining for Pneumocystis jirovecii on bronchoalveolar lavage cytologic specimens: a review |
| Q41871161 | Validation of the MycAssay Pneumocystis kit for detection of Pneumocystis jirovecii in bronchoalveolar lavage specimens by comparison to a laboratory standard of direct immunofluorescence microscopy, real-time PCR, or conventional PCR. |
| Q40200448 | Vancomycin resistant enterococcus bacteremia in a patient with Pneumocystis jiroveci pneumonia, granulocystic sarcoma and acute respiratory distress syndrome |
| Q91241341 | Variability of Pneumocystis jirovecii prophylaxis use among pediatric solid organ transplant providers |
| Q36922610 | Variation in the major surface glycoprotein genes in Pneumocystis jirovecii |
| Q91579332 | Veno-Venous Extracorporeal Membrane Oxygenation for Severe Pneumocystis jirovecii Pneumonia in an Immunocompromised Patient without HIV Infection |
| Q54257968 | Venovenous extracorporeal life support in patients with HIV infection and Pneumocystis jirovecii pneumonia. |
| Q43156828 | Vertical transmission of Pneumocystis jirovecii in humans. |
| Q40519205 | Very recent HIV infection accompanied by Pneumocystis jirovecii pneumonia and Mycobacterium avium complex immune reconstitution inflammatory syndrome: a case report. |
| Q40571424 | Virtual Screening of Phytochemicals to Novel Target (HAT) Rtt109 in Pneumocystis Jirovecii using Bioinformatics Tools |
| Q43254674 | Vitamin D metabolite-mediated hypercalcemia with suppressed parathormone concentration in Pneumocystis jiroveci pneumonia after kidney transplantation |
| Q95785268 | What prophylaxis schedule should we use for Pneumocystis jiroveci pneumonia in our liver transplant recipients? |
| Q34788682 | When is it safe to stop Pneumocystis jiroveci pneumonia prophylaxis? Insights from three cases complicating autoimmune diseases |
| Q81473074 | Withdrawal of Pneumocystis jirovecii prophylaxis in HIV-infected children under highly active antiretroviral therapy |
| Q94595746 | X-Linked Hyper IgM Syndrome Manifesting as Recurrent Pneumocystis jirovecii Pneumonia: A Case Report |
| Q42770597 | X-linked agammaglobulinemia presenting as polymicrobial pneumonia, including Pneumocystis jirovecii. |
| Q36964667 | Yield of primary and repeat induced sputum testing for Pneumocystis jiroveci in human immunodeficiency virus-positive and -negative patients |
| Q103790714 | [A child with hypercalcemia associated with pneumocystis jirovecii pneumonia] |
| Q54303651 | [Case report; Polymerase chain reaction positivity of Pneumocystis jirovecii during primary lung cancer treatment]. |
| Q91333632 | [Clinical Features of Pneumocystis Jiroveci Pneumonia in Patients with Inflammatory Bowel Disease] |
| Q99204227 | [Clinical-epidemiological characteristics of Pneumocystis jirovecii pneumonia in a tertiary hospital in Spain] |
| Q80157095 | [Cotrimoxazole Pneumocystis jiroveci pneumonia treatment failure: co-infection cytomegalovirus role?] |
| Q84466602 | [Diagnosis and treatment of pneumocystis jirovecii pneumonia] |
| Q91109100 | [Epidemiological characteristics of Pneumocystis jirovecii infection and colonization in non-AIDS patients] |
| Q98208953 | [Evaluation of Real-Time Polymerase Chain Reaction in Pneumocystis jirovecii Laboratory Diagnosis] |
| Q53895535 | [Genotypic resistance to sulfamide drugs among patients with Pneumocystis jiroveci pneumonia]. |
| Q95583160 | [Immune reconstitution syndrome in an HIV-infected patient and Pneumocystis jirovecii pneumonia] |
| Q101238480 | [Investigation of Pneumocystis jirovecii Infection and Colonization in Immunocompromised Patients with Pneumonia] |
| Q54172221 | [Investigation of Pneumocystis jirovecii colonization in patients with pulmonary diseases]. |
| Q85039003 | [Laboratory diagnosis of HIV/AIDS patients complicated with Pneumocystis jirovecii pneumonia] |
| Q54287062 | [Laboratory survey on the incidence of Pneumocystis jirovecii - obviously a peculiar fungus, but also a rare pathogen?]. |
| Q46017315 | [Mutations of drug target molecules in Pneumocystis jirovecii isolates and future investigations]. |
| Q52805176 | [Pneumocystis jiroveci infection in immunocompetent patients with pulmonary disorders, in Portugal]. |
| Q80078825 | [Pneumocystis jiroveci pneumonia characteristics in adults with AIDS with or without antiretroviral therapy] |
| Q81483273 | [Pneumocystis jiroveci pneumonia during infliximab therapy] |
| Q87905804 | [Pneumocystis jiroveci pneumonia following infliximab therapy in patient with Crohn's disease] |
| Q84289703 | [Pneumocystis jiroveci pneumonia in a Crohn's disease patient treated with adalimumab] |
| Q52932006 | [Pneumocystis jiroveci pneumonia in immunocompromised patients without AIDS -- a case series]. |
| Q80617663 | [Pneumocystis jiroveci pneumonia in patients with cancer: is it unavoidable?] |
| Q95522593 | [Pneumocystis jiroveci pneumonia: Clinical characteristics and mortality risk factors in an Intensive Care Unit] |
| Q53528865 | [Pneumocystis jiroveci pneumonia]. |
| Q83952152 | [Pneumocystis jiroveci: a new name for an old pathogen] |
| Q84347004 | [Pneumocystis jiroveci: epidemiological, pathophysiological and biological update] |
| Q91784133 | [Pneumocystis jirovecii and quantitative PCR: Pneumonia or colonization?] |
| Q89515100 | [Pneumocystis jirovecii colonisation in pregnant women and newborns in Lima, Peru] |
| Q92951284 | [Pneumocystis jirovecii detection in HIV/AIDS patients in a hospital in Peru] |
| Q84482793 | [Pneumocystis jirovecii pneumonia in HIV-infected patients] |
| Q92026770 | [Pneumocystis jirovecii pneumonia-an opportunistic infection undergoing change] |
| Q80237740 | [Pneumocystis jirovecii pneumonia: an old disease with a new name] |
| Q86197794 | [Pneumocystis jirovecii: one hundred years of history] |
| Q81881611 | [Pneumocystis pneumonia (PCP)--Pneumocystis carinii pneumonia (Syn. Pneumocystis jirovecii pneumonia)] |
| Q54447724 | [Positive Pneumocystis jirovecii PCR in immunocompromised patients with a systemic disease: infection or colonisation?]. |
| Q54119007 | [Prevalence of Pneumocystis jiroveci pneumonia in Tunisian primary immunodeficient patients]. |
| Q52681837 | [Research progress on genes mutations related to sulfa drug resistance in Pneumocystis jirovecii]. |
| Q57455034 | [Risk factors and prophylaxis of Pneumocystis jirovecii pneumonia in HIV-negative patients] |
| Q84869014 | [Serological evaluation of the prevalence of Pneumocystis jirovecii infection in children with respiratory tract infections in Poland] |
| Q88396405 | [Severe hypoxemic respiratory failure caused by Pneumocystis jirovecii in a late kidney transplant recipient] |
| Q54686679 | [Severe infection by Pneumocystis jirovecii in infants with West's syndrome treated with intramuscular adrenocorticotropic hormone]. |
| Q100529499 | [Simultaneous diagnosis and favorable evolution of infection with Pneumocystis jirovecii, SARS-CoV-2 and advanced HIV] |
| Q81423105 | [Use of restriction fragment length polymorphism to detect dihydropteroate synthase gene mutations in strains of Pneumocystis jirovecii isolated in Poland] |
| Q83742012 | β-d-Glucan kinetics for the assessment of treatment response in Pneumocystis jirovecii pneumonia |
| Q62116457 | Pneumocystis jirovecii SE8 | parent taxon | P171 |
| Q15401586 | pneumocystis pneumonia | has cause | P828 |
| Category:Pneumocystis jirovecii | wikimedia | |
| Arabic (ar / Q13955) | متكيسة رئوية جؤجؤية | wikipedia |
| Egyptian Arabic (arz / Q29919) | متكيسه رئويه جؤجؤيه | wikipedia |
| Catalan (ca / Q7026) | Pneumocystis jirovecii | wikipedia |
| ceb | Pneumocystis jirovecii | wikipedia |
| Pneumocystis jirovecii | wikipedia | |
| Pneumocystis jirovecii | wikipedia | |
| Pneumocystis jirovecii | wikipedia | |
| Pneumocystis jirovecii | wikipedia | |
| Persian (fa / Q9168) | پنوموسیستیس جیرووسی | wikipedia |
| Pneumocystis jirovecii | wikipedia | |
| Pneumocystis jirovecii | wikipedia | |
| gl | Pneumocystis jirovecii | wikipedia |
| Pneumocystis jirovecii | wikipedia | |
| ニューモシスチス・イロベチイ | wikipedia | |
| mk | Pneumocystis jirovecii | wikipedia |
| nb | Pneumocystis jirovecii | wikipedia |
| Pneumocystis jiroveci | wikipedia | |
| Pneumocystis jiroveci | wikipedia | |
| Pneumocystis jirovecii | wikipedia | |
| Pneumocystis jirovecii | wikipedia | |
| Pneumocystis jiroveci | wikipedia | |
| Pneumocystis jirovecii | wikipedia | |
| szl | Pneumocystis jirovecii | wikipedia |
| Pneumocystis jirovecii | wikipedia | |
| war | Pneumocystis jirovecii | wikipedia |
Search more.
